1
|
Jakobus P, Müller B, Heger A, Zha S, Powell J, Motornenko A, Steinheimer J, Stöcker H. Gravitational Waves from a Core g Mode in Supernovae as Probes of the High-Density Equation of State. Phys Rev Lett 2023; 131:191201. [PMID: 38000402 DOI: 10.1103/physrevlett.131.191201] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 01/16/2023] [Revised: 04/18/2023] [Accepted: 09/29/2023] [Indexed: 11/26/2023]
Abstract
Using relativistic supernova simulations of massive progenitor stars with a quark-hadron equation of state (EOS) and a purely hadronic EOS, we identify a distinctive feature in the gravitational-wave signal that originates from a buoyancy-driven mode (g mode) below the proto-neutron star convection zone. The mode frequency lies in the range 200≲f≲800 Hz and decreases with time. As the mode lives in the core of the proto-neutron star, its frequency and power are highly sensitive to the EOS, in particular the sound speed around twice saturation density.
Collapse
Affiliation(s)
- Pia Jakobus
- School of Physics and Astronomy, Monash University, Clayton, VIC 3800, Australia
| | - Bernhard Müller
- School of Physics and Astronomy, Monash University, Clayton, VIC 3800, Australia
| | - Alexander Heger
- School of Physics and Astronomy, Monash University, Clayton, VIC 3800, Australia
| | - Shuai Zha
- Yunnan Observatories, Chinese Academy of Sciences (CAS), Kunming 650216, China; Key Laboratory for the Structure and Evolution of Celestial Objects, CAS, Kunming 650216, China; and International Centre of Supernovae, Yunnan Key Laboratory, Kunming 650216, China
| | - Jade Powell
- Centre for Astrophysics and Supercomputing, Swinburne University of Technology, Hawthorn, VIC 3122, Australia
| | - Anton Motornenko
- Frankfurt Institute for Advanced Studies, Giersch Science Center, Frankfurt am Main, Germany
| | - Jan Steinheimer
- Frankfurt Institute for Advanced Studies, Giersch Science Center, Frankfurt am Main, Germany
| | - Horst Stöcker
- Frankfurt Institute for Advanced Studies, Giersch Science Center, Frankfurt am Main, Germany
| |
Collapse
|
2
|
Luen SJ, Viale G, Nik-Zainal S, Savas P, Kammler R, Dell'Orto P, Biasi O, Degasperi A, Brown LC, Láng I, MacGrogan G, Tondini C, Bellet M, Villa F, Bernardo A, Ciruelos E, Karlsson P, Neven P, Climent M, Müller B, Jochum W, Bonnefoi H, Martino S, Davidson NE, Geyer C, Chia SK, Ingle JN, Coleman R, Solbach C, Thürlimann B, Colleoni M, Coates AS, Goldhirsch A, Fleming GF, Francis PA, Speed TP, Regan MM, Loi S. Genomic characterisation of hormone receptor-positive breast cancer arising in very young women. Ann Oncol 2023; 34:397-409. [PMID: 36709040 PMCID: PMC10619213 DOI: 10.1016/j.annonc.2023.01.009] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/09/2022] [Revised: 12/14/2022] [Accepted: 01/15/2023] [Indexed: 01/26/2023] Open
Abstract
BACKGROUND Very young premenopausal women diagnosed with hormone receptor-positive, human epidermal growth factor receptor 2-negative (HR+HER2-) early breast cancer (EBC) have higher rates of recurrence and death for reasons that remain largely unexplained. PATIENTS AND METHODS Genomic sequencing was applied to HR+HER2- tumours from patients enrolled in the Suppression of Ovarian Function Trial (SOFT) to determine genomic drivers that are enriched in young premenopausal women. Genomic alterations were characterised using next-generation sequencing from a subset of 1276 patients (deep targeted sequencing, n = 1258; whole-exome sequencing in a young-age, case-control subsample, n = 82). We defined copy number (CN) subgroups and assessed for features suggestive of homologous recombination deficiency (HRD). Genomic alteration frequencies were compared between young premenopausal women (<40 years) and older premenopausal women (≥40 years), and assessed for associations with distant recurrence-free interval (DRFI) and overall survival (OS). RESULTS Younger women (<40 years, n = 359) compared with older women (≥40 years, n = 917) had significantly higher frequencies of mutations in GATA3 (19% versus 16%) and CN amplifications (CNAs) (47% versus 26%), but significantly lower frequencies of mutations in PIK3CA (32% versus 47%), CDH1 (3% versus 9%), and MAP3K1 (7% versus 12%). Additionally, they had significantly higher frequencies of features suggestive of HRD (27% versus 21%) and a higher proportion of PIK3CA mutations with concurrent CNAs (23% versus 11%). Genomic features suggestive of HRD, PIK3CA mutations with CNAs, and CNAs were associated with significantly worse DRFI and OS compared with those without these features. These poor prognostic features were enriched in younger patients: present in 72% of patients aged <35 years, 54% aged 35-39 years, and 40% aged ≥40 years. Poor prognostic features [n = 584 (46%)] versus none [n = 692 (54%)] had an 8-year DRFI of 84% versus 94% and OS of 88% versus 96%. Younger women (<40 years) had the poorest outcomes: 8-year DRFI 74% versus 85% and OS 80% versus 93%, respectively. CONCLUSION These results provide insights into genomic alterations that are enriched in young women with HR+HER2- EBC, provide rationale for genomic subgrouping, and highlight priority molecular targets for future clinical trials.
Collapse
Affiliation(s)
- S J Luen
- Department of Medical Oncology, Peter MacCallum Cancer Centre, Melbourne, Australia; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, Australia
| | - G Viale
- International Breast Cancer Study Group Central Pathology Office, IEO European Institute of Oncology IRCCS, University of Milan, Milan, Italy
| | - S Nik-Zainal
- Department of Medical Genetics & MRC Cancer Unit, The Clinical School, University of Cambridge, Cambridge, UK
| | - P Savas
- Department of Medical Oncology, Peter MacCallum Cancer Centre, Melbourne, Australia; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, Australia
| | - R Kammler
- International Breast Cancer Study Group, Coordinating Center, Central Pathology Office, Bern, Switzerland
| | - P Dell'Orto
- International Breast Cancer Study Group Central Pathology Office, Department of Pathology, IEO European Institute of Oncology IRCCS, Milan, Italy
| | - O Biasi
- Division of Pathology and Laboratory Medicine, IEO European Institute of Oncology IRCCS, Milan, Italy
| | - A Degasperi
- Department of Medical Genetics & MRC Cancer Unit, The Clinical School, University of Cambridge, Cambridge, UK
| | - L C Brown
- Department of Medical Oncology, Peter MacCallum Cancer Centre, Melbourne, Australia; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, Australia
| | - I Láng
- Istenhegyi Health Center Oncology Clinic, National Institute of Oncology, Budapest, Hungary
| | - G MacGrogan
- Biopathology Department, Institut Bergonié Comprehensive Cancer Centre, Bordeaux, France
| | - C Tondini
- Osp. Papa Giovanni XXIII, Bergamo, Italy
| | - M Bellet
- Vall d'Hebron Institute of Oncology (VHIO) and Vall d'Hebron University Hospital, Barcelona, Spain
| | - F Villa
- Oncology Unit, Department of Oncology, Alessandro Manzoni Hospital, ASST Lecco, Lecco, Italy
| | - A Bernardo
- ICS Maugeri IRCCS, Medical Oncology Unit of Pavia Institute, Italy
| | - E Ciruelos
- University Hospital 12 de Octubre, Madrid, Spain
| | - P Karlsson
- Department of Oncology, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden
| | - P Neven
- Gynecologic Oncology and Multidisciplinary Breast Center, University Hospitals UZ-Leuven, KU Leuven, Leuven, Belgium
| | - M Climent
- Instituto Valenciano de Oncologia, Valencia, Spain
| | - B Müller
- Chilean Cooperative Group for Oncologic Research (GOCCHI), Santiago, Chile
| | - W Jochum
- Institute of Pathology, Cantonal Hospital St. Gallen, St. Gallen, Switzerland; Swiss Group for Clinical Cancer Research (SAKK), Berne, Switzerland
| | - H Bonnefoi
- Institut Bergonié Comprehensive Cancer Centre, Université de Bordeaux, INSERM U1218, Bordeaux, France; European Organization for Research and Treatment of Cancer (EORTC), Brussels, Belgium
| | - S Martino
- The Angeles Clinic and Research Institute, Santa Monica, USA
| | - N E Davidson
- Fred Hutchinson Cancer Research Center, University of Washington, Seattle, USA
| | - C Geyer
- Houston Methodist Cancer Center, NRG Oncology, Houston, USA
| | - S K Chia
- BC Cancer and Canadian Cancer Trials Group, Vancouver, Canada
| | - J N Ingle
- Mayo Clinic, Rochester, Minnesota, USA
| | - R Coleman
- National Institute for Health Research (NIHR) Cancer Research Network, University of Sheffield, Sheffield, UK
| | - C Solbach
- Breast Center, University Hospital, Goethe University Frankfurt, Frankfurt, Germany
| | - B Thürlimann
- Swiss Group for Clinical Cancer Research (SAKK), Berne, Switzerland; Breast Center, Kantonsspital, St. Gallen, Switzerland
| | - M Colleoni
- Division of Medical Senology, IEO, European Institute of Oncology IRCCS, Milan, Italy
| | - A S Coates
- International Breast Cancer Study Group and University of Sydney, Sydney, Australia
| | - A Goldhirsch
- International Breast Cancer Study Group (IBCSG), Bern Switzerland and IEO European Institute of Oncology IRCCS, Milan, Italy
| | - G F Fleming
- Section of Hematology Oncology, The University of Chicago, Chicago, USA
| | - P A Francis
- Department of Medical Oncology, Peter MacCallum Cancer Centre, Melbourne, Australia; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, Australia
| | - T P Speed
- Bioinformatics Division, Walter and Eliza Hall Institute, Melbourne, Australia
| | - M M Regan
- Division of Biostatistics, International Breast Cancer Study Group Statistical Center, Dana-Farber Cancer Institute, Harvard Medical School, Boston, USA
| | - S Loi
- Department of Medical Oncology, Peter MacCallum Cancer Centre, Melbourne, Australia; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, Australia.
| |
Collapse
|
3
|
Thiem A, Mashhadiakbar P, Cussigh C, Hassel JC, Grimmelmann I, Gutzmer R, Schlaak M, Heppt MV, Dücker P, Hüning S, Schulmeyer L, Schilling B, Haferkamp S, Ziemer M, Moritz RKC, Hagelstein V, Terheyden P, Posch C, Gaiser MR, Kropp P, Emmert S, Müller B, Tietze JK. Immune checkpoint inhibition and targeted therapy for melanoma: A patient‐oriented cross‐sectional comparative multicenter study. J Eur Acad Dermatol Venereol 2022; 37:884-893. [PMID: 36433671 DOI: 10.1111/jdv.18778] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/03/2022] [Accepted: 11/08/2022] [Indexed: 11/27/2022]
Abstract
BACKGROUND Choosing the adequate systemic treatment for melanoma is driven by clinical parameters and personal preferences. OBJECTIVE Evaluation of the impact of disease and treatment on the daily life of patients receiving systemic therapy for melanoma. METHODS A German-wide, cross-sectional comparative study was conducted at 13 specialized skin cancer centres from 08/2020 to 03/2021. A questionnaire was distributed to assess patients' perception of disease and symptoms, the impact of their current treatment on quality of life (QOL) and activities, adverse events (AEs), therapeutic visits, as well as believe in and satisfaction with their current systemic melanoma treatment. Patient-reported outcomes (PROs) were rated on a continuous numerical rating scale or selected from a given list. RESULTS Four hundred and fourteen patients with systemic melanoma therapy were included. 359 (87%) received immune checkpoint inhibition (ICI) and 55 (13%) targeted therapy (TT). About 1/3 of patients were adjuvantly treated, the remaining because of unresectable/metastatic melanoma. In subgroup analyses, only in the adjuvant setting, TT patients reported a significant decrease in their treatment associated QOL compared to patients with ICI (p = 0.02). Patients with TT were 1.9 times more likely to report AEs than patients with ICI, a difference being significant just for the adjuvant setting (p = 0.01). ICI treatment intervals differed significantly between adjuvant and unresectable/metastatic setting (p = 0.04), though all patients, regardless of their specific ICI drug, evaluated their treatment frequency as adequate. TT patients with dabrafenib/trametinib (n = 37) or encorafenib/binimetinib (n = 15) did not differ regarding the strain of daily pill intake. Patients older than 63 years rated various PROs better than younger patients. CONCLUSIONS Patients evaluated their treatment mainly positively. ICI might be preferred over TT regarding QOL and patient-reported AEs in the adjuvant setting. Older melanoma patients appeared to be less impacted by their disease and more satisfied with their treatment.
Collapse
Affiliation(s)
- A. Thiem
- Clinic and Policlinic for Dermatology and Venereology University Medical Center Rostock Rostock Germany
| | - P. Mashhadiakbar
- Clinic and Policlinic for Dermatology and Venereology University Medical Center Rostock Rostock Germany
| | - C. Cussigh
- Department of Dermatology and National Center for Tumor Diseases (NCT) Heidelberg University Hospital Heidelberg Germany
| | - J. C. Hassel
- Department of Dermatology and National Center for Tumor Diseases (NCT) Heidelberg University Hospital Heidelberg Germany
| | - I. Grimmelmann
- Skin Cancer Center Hannover, Department of Dermatology Hannover Medical School Hannover Germany
| | - R. Gutzmer
- Skin Cancer Center Hannover, Department of Dermatology Hannover Medical School Hannover Germany
- Skin Cancer Center Minden, Department of Dermatology, Johannes‐Wesling‐Klinikum Minden/Ruhr‐University, Bochum Minden Germany
| | - M. Schlaak
- Department of Dermatology and Allergy University Hospital of Munich (LMU) Munich Germany
- Charité – Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt‐Universität zu Berlin, Department of Dermatology, Venereology and Allergology Berlin Germany
| | - M. V. Heppt
- Department of Dermatology and Comprehensive Cancer Center Erlangen‐European Metropolitan Area of Nuremberg (CCC ER‐EMN), Universitätsklinikum Erlangen, Friedrich‐Alexander‐University Erlangen‐Nürnberg Erlangen Germany
| | - P. Dücker
- Department of Dermatology, Hospital of Dortmund Dortmund Germany
| | - S. Hüning
- Department of Dermatology, Hospital of Dortmund Dortmund Germany
| | - L. Schulmeyer
- Department of Dermatology, Venereology and Allergology University Hospital Würzburg Würzburg Germany
| | - B. Schilling
- Department of Dermatology, Venereology and Allergology University Hospital Würzburg Würzburg Germany
| | - S. Haferkamp
- Department of Dermatology University Hospital Regensburg Regensburg Germany
| | - M. Ziemer
- Department of Dermatology, Venereology and Allergology University Medical Center Leipzig Leipzig Germany
| | - R. K. C. Moritz
- Charité – Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt‐Universität zu Berlin, Department of Dermatology, Venereology and Allergology Berlin Germany
- Department of Dermatology and Venereology, Martin‐Luther‐University Halle‐Wittenberg Halle (Saale) Germany
| | - V. Hagelstein
- Department of Dermatology, Allergology, and Venereology University of Lübeck Germany
| | - P. Terheyden
- Department of Dermatology, Allergology, and Venereology University of Lübeck Germany
| | - C. Posch
- Department of Dermatology, Venereology and Allergology, Clinic Hietzing Vienna Healthcare Group Vienna Austria
- Department of Dermatology and Allergy, School of Medicine, German Cancer Consortium (DKTK) Technical University of Munich Munich Germany
- Faculty of Medicine Sigmund Freud University Vienna Vienna Austria
| | - M. R. Gaiser
- Department of Dermatology, Venerology and Allergology, Medical Faculty Mannheim, University Medical Center Mannheim Heidelberg University Mannheim Germany
- Skin Cancer Unit, German Cancer Research Center (DKFZ), Heidelberg Germany
| | - P. Kropp
- Institute of Medical Psychology and Medical Sociology University Medical Center Rostock Rostock Germany
| | - S. Emmert
- Clinic and Policlinic for Dermatology and Venereology University Medical Center Rostock Rostock Germany
| | - B. Müller
- Institute of Medical Psychology and Medical Sociology University Medical Center Rostock Rostock Germany
| | - J. K. Tietze
- Clinic and Policlinic for Dermatology and Venereology University Medical Center Rostock Rostock Germany
| |
Collapse
|
4
|
Jakobus P, Müller B, Heger A, Motornenko A, Steinheimer J, Stoecker H. The role of the hadron-quark phase transition in core-collapse supernovae. Mon Not R Astron Soc 2022; 516:2554-2574. [PMID: 36117590 PMCID: PMC9467458 DOI: 10.1093/mnras/stac2352] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Received: 04/21/2022] [Revised: 08/17/2022] [Accepted: 08/17/2022] [Indexed: 06/15/2023]
Abstract
The hadron-quark phase transition in quantum chromodynamics has been suggested as an alternative explosion mechanism for core-collapse supernovae. We study the impact of three different hadron-quark equations of state (EoS) with first-order (DD2F_SF, STOS-B145) and second-order (CMF) phase transitions on supernova dynamics by performing 97 simulations for solar- and zero-metallicity progenitors in the range of [Formula: see text]. We find explosions only for two low-compactness models (14 and [Formula: see text]) with the DD2F_SF EoS, both with low explosion energies of [Formula: see text]. These weak explosions are characterized by a neutrino signal with several minibursts in the explosion phase due to complex reverse shock dynamics, in addition to the typical second neutrino burst for phase-transition-driven explosions. The nucleosynthesis shows significant overproduction of nuclei such as 90Zr for the [Formula: see text] zero-metallicity model and 94Zr for the [Formula: see text] solar-metallicity model, but the overproduction factors are not large enough to place constraints on the occurrence of such explosions. Several other low-compactness models using the DD2F_SF EoS and two high-compactness models using the STOS EoS end up as failed explosions and emit a second neutrino burst. For the CMF EoS, the phase transition never leads to a second bounce and explosion. For all three EoS, inverted convection occurs deep in the core of the protocompact star due to anomalous behaviour of thermodynamic derivatives in the mixed phase, which heats the core to entropies up to 4k B/baryon and may have a distinctive gravitational-wave signature, also for a second-order phase transition.
Collapse
Affiliation(s)
- Pia Jakobus
- School of Physics and Astronomy, Monash University, Clayton, VIC 3800, Australia
- Australian Research Council Centre of Excellence for Gravitational Wave Discovery (OzGrav), Clayton, VIC 3800, Australia
| | - Bernhard Müller
- School of Physics and Astronomy, Monash University, Clayton, VIC 3800, Australia
- Australian Research Council Centre of Excellence for Gravitational Wave Discovery (OzGrav), Clayton, VIC 3800, Australia
| | - Alexander Heger
- School of Physics and Astronomy, Monash University, Clayton, VIC 3800, Australia
- Australian Research Council Centre of Excellence for Gravitational Wave Discovery (OzGrav), Clayton, VIC 3800, Australia
- Center of Excellence for Astrophysics in Three Dimensions (ASTRO-3D), Canberra, ACT 2611, Australia
- The Joint Institute for Nuclear Astrophysics, Michigan State University, East Lansing, MI 48824, USA
| | - Anton Motornenko
- Frankfurt Institute for Advanced Studies, Giersch Science Center, Frankfurt am Main, 60438, Germany
| | - Jan Steinheimer
- Frankfurt Institute for Advanced Studies, Giersch Science Center, Frankfurt am Main, 60438, Germany
| | - Horst Stoecker
- Frankfurt Institute for Advanced Studies, Giersch Science Center, Frankfurt am Main, 60438, Germany
- Institut für Theoretische Physik, Goethe Universität, Frankfurt am Main, 60438, Germany
- GSI Helmholtzzentrum für Schwerionenforschung GmbH, Darmstadt, 64291, Germany
| |
Collapse
|
5
|
Müller B, Estay R. Letter comments on: "Twelve years of European cancer drug approval-a systematic investigation of the 'magnitude of clinical benefit'". ESMO Open 2022; 7:100487. [PMID: 35525185 PMCID: PMC9092263 DOI: 10.1016/j.esmoop.2022.100487] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/06/2022] [Accepted: 03/08/2022] [Indexed: 11/29/2022] Open
Affiliation(s)
- B Müller
- Instituto Nacional del Cáncer, Department for Medical Oncology, Santiago, Chile; Grupo Oncológico Cooperativo Chileno de Investigación, Santiago, Chile.
| | - R Estay
- Hospital del Salvador, Department for Medical Oncology, Santiago, Chile; School of Medicine, Eastern Campus, Universidad de Chile, Santiago, Chile
| |
Collapse
|
6
|
Torres-Forné A, Cerdá-Durán P, Obergaulinger M, Müller B, Font JA. Erratum: Universal Relations for Gravitational-Wave Asteroseismology of Protoneutron Stars [Phys. Rev. Lett. 123, 051102 (2019)]. Phys Rev Lett 2021; 127:239901. [PMID: 34936808 DOI: 10.1103/physrevlett.127.239901] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 11/08/2021] [Indexed: 06/14/2023]
Abstract
This corrects the article DOI: 10.1103/PhysRevLett.123.051102.
Collapse
|
7
|
Zirath H, Spitz S, Roth D, Schellhorn T, Rothbauer M, Müller B, Walch M, Kaur J, Wörle A, Kohl Y, Mayr T, Ertl P. Bridging the academic-industrial gap: application of an oxygen and pH sensor-integrated lab-on-a-chip in nanotoxicology. Lab Chip 2021; 21:4237-4248. [PMID: 34605521 DOI: 10.1039/d1lc00528f] [Citation(s) in RCA: 8] [Impact Index Per Article: 2.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/13/2023]
Abstract
Translation of advanced cell-based assays exhibiting a higher degree of automation, miniaturization, and integration of complementary sensing functions is mainly limited by the development of industrial-relevant prototypes that can be readily produced in larger volumes. Despite the increasing number of academic publications in recent years, the manufacturability of these microfluidic cell cultures systems is largely ignored, thus severely restricting their implementation in routine toxicological applications. We have developed a dual-sensor integrated microfluidic cell analysis platform using industrial specifications, materials, and fabrication methods to conduct risk assessment studies of engineered nanoparticles to overcome this academic-industrial gap. Non-invasive and time-resolved monitoring of cellular oxygen uptake and metabolic activity (pH) in the absence and presence of nanoparticle exposure is accomplished by integrating optical sensor spots into a cyclic olefin copolymer (COC)-based microfluidic platform. Results of our nanotoxicological study, including two physiological cell barriers that are essential in the protection from exogenous factors, the intestine (Caco-2) and the vasculature (HUVECs) showed that the assessment of the cells' total energy metabolism is ideally suited to rapidly detect cytotoxicities. Additional viability assay verification using state-of-the-art dye exclusion assays for nanotoxicology demonstrated the similarity and comparability of our results, thus highlighting the benefits of employing a compact and cost-efficient microfluidic dual-sensor platform as a pre-screening tool in nanomaterial risk assessment and as a rapid quality control measure in medium to high-throughput settings.
Collapse
Affiliation(s)
- Helene Zirath
- Institute of Applied Synthetic Chemistry and Institute of Chemical Technologies and Analytics, Faculty of Technical Chemistry, Vienna University of Technology, Getreidemarkt 9/163-164, 1060 Vienna, Austria.
- Austrian Cluster for Tissue Regeneration, Vienna, Austria
| | - Sarah Spitz
- Institute of Applied Synthetic Chemistry and Institute of Chemical Technologies and Analytics, Faculty of Technical Chemistry, Vienna University of Technology, Getreidemarkt 9/163-164, 1060 Vienna, Austria.
- Austrian Cluster for Tissue Regeneration, Vienna, Austria
| | - Doris Roth
- Institute of Applied Synthetic Chemistry and Institute of Chemical Technologies and Analytics, Faculty of Technical Chemistry, Vienna University of Technology, Getreidemarkt 9/163-164, 1060 Vienna, Austria.
- Austrian Cluster for Tissue Regeneration, Vienna, Austria
| | - Tobias Schellhorn
- Institute of Applied Synthetic Chemistry and Institute of Chemical Technologies and Analytics, Faculty of Technical Chemistry, Vienna University of Technology, Getreidemarkt 9/163-164, 1060 Vienna, Austria.
| | - Mario Rothbauer
- Austrian Cluster for Tissue Regeneration, Vienna, Austria
- Karl Chiari Lab for Orthopaedic Biology, Department of Orthopedics and Trauma Surgery, Medical University of Vienna, Währinger Gürtel 18-20, 1090 Vienna, Austria
| | - Bernhard Müller
- Institute of Analytical Chemistry and Food Chemistry, Graz University of Technology, Stremayrgasse 9, 8010 Graz, Austria
| | - Manuel Walch
- kdg opticomp GmbH, Am kdg Campus, Dorf 91, 6652 Elbigenalp, Austria
| | - Jatinder Kaur
- kdg opticomp GmbH, Am kdg Campus, Dorf 91, 6652 Elbigenalp, Austria
| | - Alexander Wörle
- kdg opticomp GmbH, Am kdg Campus, Dorf 91, 6652 Elbigenalp, Austria
| | - Yvonne Kohl
- Fraunhofer Institute for Biomedical Engineering IBMT, 66280 Sulzbach, Germany
| | - Torsten Mayr
- Institute of Analytical Chemistry and Food Chemistry, Graz University of Technology, Stremayrgasse 9, 8010 Graz, Austria
| | - Peter Ertl
- Institute of Applied Synthetic Chemistry and Institute of Chemical Technologies and Analytics, Faculty of Technical Chemistry, Vienna University of Technology, Getreidemarkt 9/163-164, 1060 Vienna, Austria.
- Austrian Cluster for Tissue Regeneration, Vienna, Austria
| |
Collapse
|
8
|
Jerusalem G, Farah S, Courtois A, Chirgwin J, Aebi S, Karlsson P, Neven P, Hitre E, Graas MP, Simoncini E, Abdi E, Kamby C, Thompson A, Loibl S, Gavilá J, Kuroi K, Marth C, Müller B, O'Reilly S, Gombos A, Ruhstaller T, Burstein HJ, Rabaglio M, Ruepp B, Ribi K, Viale G, Gelber RD, Coates AS, Loi S, Goldhirsch A, Regan MM, Colleoni M. Continuous versus intermittent extended adjuvant letrozole for breast cancer: final results of randomized phase III SOLE (Study of Letrozole Extension) and SOLE Estrogen Substudy. Ann Oncol 2021; 32:1256-1266. [PMID: 34384882 DOI: 10.1016/j.annonc.2021.07.017] [Citation(s) in RCA: 14] [Impact Index Per Article: 4.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/12/2021] [Revised: 07/28/2021] [Accepted: 07/29/2021] [Indexed: 02/07/2023] Open
Abstract
BACKGROUND Late recurrences in postmenopausal women with hormone receptor-positive breast cancers remain an important challenge. Avoidance or delayed development of resistance represents the main objective in extended endocrine therapy (ET). In animal models, resistance was reversed with restoration of circulating estrogen levels during interruption of letrozole treatment. This phase III, randomized, open-label Study of Letrozole Extension (SOLE) studied the effect of extended intermittent letrozole treatment in comparison with continuous letrozole. In parallel, the SOLE estrogen substudy (SOLE-EST) analyzed the levels of estrogen during the interruption of treatment. PATIENTS AND METHODS SOLE enrolled 4884 postmenopausal women with hormone receptor-positive, lymph node-positive, operable breast cancer between December 2007 and October 2012 and among them, 104 patients were enrolled in SOLE-EST. They must have undergone local treatment and have completed 4-6 years of adjuvant ET. Patients were randomized between continuous letrozole (2.5 mg/day orally for 5 years) and intermittent letrozole treatment (2.5 mg/day for 9 months followed by a 3-month interruption in years 1-4 and then 2.5 mg/day during all of year 5). RESULTS Intention-to-treat population included 4851 women in SOLE (n = 2425 in the intermittent and n = 2426 in the continuous letrozole groups) and 103 women in SOLE-EST (n = 78 in the intermittent and n = 25 in the continuous letrozole groups). After a median follow-up of 84 months, 7-year disease-free survival (DFS) was 81.4% in the intermittent group and 81.5% in the continuous group (hazard ratio: 1.03, 95% confidence interval: 0.91-1.17). Reported adverse events were similar in both groups. Circulating estrogen recovery was demonstrated within 6 weeks after the stop of letrozole treatment. CONCLUSIONS Extended adjuvant ET by intermittent administration of letrozole did not improve DFS compared with continuous use, despite the recovery of circulating estrogen levels. The similar DFS coupled with previously reported quality-of-life advantages suggest intermittent extended treatment is a valid option for patients who require or prefer a treatment interruption.
Collapse
Affiliation(s)
- G Jerusalem
- International Breast Cancer Study Group, Bern, Switzerland; Medical Oncology Department, CHU Liège, Liège University, Liège, Belgium.
| | - S Farah
- International Breast Cancer Study Group Statistical Center, Division of Biostatistics, Dana-Farber Cancer Institute, Boston, USA
| | - A Courtois
- Medical Oncology Department, CHU Liège, Liège University, Liège, Belgium
| | - J Chirgwin
- Breast Cancer Trials-Australia and New Zealand, University of Newcastle, Callaghan, Australia; Box Hill and Maroondah Hospitals, Monash University, Clayton, Australia
| | - S Aebi
- Division of Medical Oncology, Cancer Center, Lucerne Cantonal Hospital, Lucerne, Switzerland; Faculty of Medicine, University of Bern, Bern, Switzerland
| | - P Karlsson
- Department of Oncology, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden
| | - P Neven
- Gynecologic Oncology and Multidisciplinary Breast Center, University Hospitals UZ-Leuven, KU Leuven, Leuven, Belgium
| | - E Hitre
- Department of Medical Oncology and Clinical Pharmacology "B", National Institute of Oncology, Budapest, Hungary
| | | | - E Simoncini
- ASST Spedali Civili di Brescia, Brescia, Italy
| | - E Abdi
- The Tweed Hospital, Griffith University Gold Coast, Tweed Heads, Australia
| | - C Kamby
- Danish Breast Cancer Group and Rigshospitalet, Copenhagen, Denmark
| | - A Thompson
- Scottish Cancer Trials Breast Group and Division of Surgical Oncology, Baylor College of Medicine, Houston, USA
| | - S Loibl
- German Breast Group Forschungs GmbH, Neu-Isenburg, Germany
| | - J Gavilá
- SOLTI Group and Fundación Instituto Valenciano de Oncologia, Valencia, Spain
| | - K Kuroi
- Japan Breast Cancer Research Group and Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital, Tokyo, Japan
| | - C Marth
- Austrian Breast & Colorectal Cancer Study Group and Department of Obstetrics and Gynecology, Medical University Innsbruck, Innsbruck, Austria
| | - B Müller
- Chilean Cooperative Group for Oncologic Research (GOCCHI), Providencia, Santiago, Chile
| | - S O'Reilly
- Cancer Trials Ireland, Dublin, Ireland; University College Cork, Cork University Hospital, Cork, Ireland
| | - A Gombos
- Université Libre de Bruxelles, Institut Jules Bordet, Brussels, Belgium
| | - T Ruhstaller
- International Breast Cancer Study Group, Bern, Switzerland; Swiss Group for Clinical Cancer Research SAKK, Bern, Switzerland; Breast Center St. Gallen, St. Gallen, Switzerland; Faculty of Medicine, University of Basel, Basel, Switzerland
| | - H J Burstein
- Medical Oncology Department, CHU Liège, Liège University, Liège, Belgium; Harvard Medical School, Boston, USA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, USA
| | - M Rabaglio
- International Breast Cancer Study Group, Bern, Switzerland; Swiss Group for Clinical Cancer Research SAKK, Bern, Switzerland; Department of Medical Oncology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland
| | - B Ruepp
- International Breast Cancer Study Group, Bern, Switzerland
| | - K Ribi
- International Breast Cancer Study Group, Bern, Switzerland
| | - G Viale
- Department of Pathology, University of Milan, Milan, Italy; IEO European Institute of Oncology IRCCS, Milan, Italy
| | - R D Gelber
- International Breast Cancer Study Group Statistical Center, Division of Biostatistics, Dana-Farber Cancer Institute, Boston, USA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, USA; Harvard TH Chan School of Public Health, Boston, USA; Frontier Science Foundation, Boston, USA
| | - A S Coates
- International Breast Cancer Study Group, Bern, Switzerland; NHMRC Clinical Trials Centre, University of Sydney, Sydney, Australia
| | - S Loi
- International Breast Cancer Study Group, Bern, Switzerland; Peter MacCallum Cancer Center, University of Melbourne, Melbourne, Australia
| | - A Goldhirsch
- International Breast Cancer Study Group, Bern, Switzerland; IEO European Institute of Oncology, IRCCS, Milan, Italy
| | - M M Regan
- International Breast Cancer Study Group Statistical Center, Division of Biostatistics, Dana-Farber Cancer Institute, Boston, USA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, USA
| | - M Colleoni
- International Breast Cancer Study Group, Bern, Switzerland; Division of Medical Senology, IEO, European Institute of Oncology, IRCCS, Milan, Italy
| | | |
Collapse
|
9
|
Ritter C, Wollmann T, Lee JY, Imle A, Müller B, Fackler OT, Bartenschlager R, Rohr K. Data fusion and smoothing for probabilistic tracking of viral structures in fluorescence microscopy images. Med Image Anal 2021; 73:102168. [PMID: 34340105 DOI: 10.1016/j.media.2021.102168] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/30/2020] [Revised: 06/10/2021] [Accepted: 07/07/2021] [Indexed: 10/20/2022]
Abstract
Automatic tracking of viral structures displayed as small spots in fluorescence microscopy images is an important task to determine quantitative information about cellular processes. We introduce a novel probabilistic approach for tracking multiple particles based on multi-sensor data fusion and Bayesian smoothing methods. The approach exploits multiple measurements as in a particle filter, both detection-based measurements and prediction-based measurements from a Kalman filter using probabilistic data association with elliptical sampling. Compared to previous probabilistic tracking methods, our approach exploits separate uncertainties for the detection-based and prediction-based measurements, and integrates them by a sequential multi-sensor data fusion method. In addition, information from both past and future time points is taken into account by a Bayesian smoothing method in conjunction with the covariance intersection algorithm for data fusion. Also, motion information based on displacements is used to improve correspondence finding. Our approach has been evaluated on data of the Particle Tracking Challenge and yielded state-of-the-art results or outperformed previous approaches. We also applied our approach to challenging time-lapse fluorescence microscopy data of human immunodeficiency virus type 1 and hepatitis C virus proteins acquired with different types of microscopes and spatial-temporal resolutions. It turned out, that our approach outperforms existing methods.
Collapse
Affiliation(s)
- C Ritter
- Biomedical Computer Vision Group, BioQuant, IPMB, Heidelberg University, Im Neuenheimer Feld 267, Heidelberg, Germany.
| | - T Wollmann
- Biomedical Computer Vision Group, BioQuant, IPMB, Heidelberg University, Im Neuenheimer Feld 267, Heidelberg, Germany
| | - J-Y Lee
- Dept. of Infectious Diseases, Molecular Virology, Heidelberg University, Im Neuenheimer Feld 344, Heidelberg, Germany; German Center for Infection Research (DZIF), Heidelberg Partner Site, Germany
| | - A Imle
- Dept. of Infectious Diseases, Integrative Virology, University Hospital Heidelberg, Im Neuenheimer Feld 344, Heidelberg, Germany; Cell Biology and Biophysics Unit, European Molecular Biology Laboratory, Meyerhofstrasse 1, Heidelberg, Germany
| | - B Müller
- Dept. of Infectious Diseases, Virology, University Hospital Heidelberg, Im Neuenheimer Feld 344, Heidelberg, Germany
| | - O T Fackler
- Dept. of Infectious Diseases, Integrative Virology, University Hospital Heidelberg, Im Neuenheimer Feld 344, Heidelberg, Germany; German Center for Infection Research (DZIF), Heidelberg Partner Site, Germany
| | - R Bartenschlager
- Dept. of Infectious Diseases, Molecular Virology, Heidelberg University, Im Neuenheimer Feld 344, Heidelberg, Germany; German Center for Infection Research (DZIF), Heidelberg Partner Site, Germany
| | - K Rohr
- Biomedical Computer Vision Group, BioQuant, IPMB, Heidelberg University, Im Neuenheimer Feld 267, Heidelberg, Germany.
| |
Collapse
|
10
|
Varma V, Müller B. 3D simulations of oxygen shell burning with and without magnetic fields. Mon Not R Astron Soc 2021; 504:636-647. [PMID: 33935581 PMCID: PMC8056252 DOI: 10.1093/mnras/stab883] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Received: 01/01/2021] [Revised: 03/03/2021] [Accepted: 03/25/2021] [Indexed: 06/12/2023]
Abstract
We present a first 3D magnetohydrodynamic (MHD) simulation of convective oxygen and neon shell burning in a non-rotating [Formula: see text] star shortly before core collapse to study the generation of magnetic fields in supernova progenitors. We also run a purely hydrodynamic control simulation to gauge the impact of the magnetic fields on the convective flow and on convective boundary mixing. After about 17 convective turnover times, the magnetic field is approaching saturation levels in the oxygen shell with an average field strength of [Formula: see text], and does not reach kinetic equipartition. The field remains dominated by small-to-medium scales, and the dipole field strength at the base of the oxygen shell is only [Formula: see text]. The angle-averaged diagonal components of the Maxwell stress tensor mirror those of the Reynolds stress tensor, but are about one order of magnitude smaller. The shear flow at the oxygen-neon shell interface creates relatively strong fields parallel to the convective boundary, which noticeably inhibit the turbulent entrainment of neon into the oxygen shell. The reduced ingestion of neon lowers the nuclear energy generation rate in the oxygen shell and thereby slightly slows down the convective flow. Aside from this indirect effect, we find that magnetic fields do not appreciably alter the flow inside the oxygen shell. We discuss the implications of our results for the subsequent core-collapse supernova and stress the need for longer simulations, resolution studies, and an investigation of non-ideal effects for a better understanding of magnetic fields in supernova progenitors.
Collapse
Affiliation(s)
- Vishnu Varma
- School of Physics and Astronomy, 10 College Walk, Monash University, Clayton VIC 3800, Australia
| | - Bernhard Müller
- School of Physics and Astronomy, 10 College Walk, Monash University, Clayton VIC 3800, Australia
- ARC Centre of Excellence for Gravitational Wave Discovery – OzGrav, Monash University, Clayton, VIC 3800, Australia
| |
Collapse
|
11
|
Lyons N, Dietrich DE, Graser J, Juckel G, Koßmann C, Krauß H, Müller B, Michalak J. Reduced Jumping to Conclusion Bias after Experimentally Induced Enhancement of Subjective Body Boundaries in Psychosis. Psychopathology 2021; 54:92-97. [PMID: 33611331 DOI: 10.1159/000513271] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 09/04/2020] [Accepted: 11/20/2020] [Indexed: 11/19/2022]
Abstract
INTRODUCTION A disturbed sense of self is frequently discussed as an etiological factor for delusion symptoms in psychosis. Phenomenological approaches to psychopathology posit that lacking the sense that the self is localized within one's bodily boundaries (disembodiment) is one of the core features of the disturbed self in psychosis. The present study examines this idea by experimentally manipulating the sense of bodily boundaries. METHODS Seventy-three patients with psychosis were randomly assigned to either a 10-min, guided self-massage in the experimental group (EG) to enhance the sense of bodily boundaries or a control group (CG), which massaged a fabric ring. Effects on an implicit measure (jumping to conclusion bias; JTC) and an explicit measure (Brief State Paranoia Checklist; BSPC) of delusion processes were assessed. The JTC measures the tendency to make a decision with little evidence available, and the BSPC explicitly measures the approval of paranoid beliefs. RESULTS Patients in the EG showed a lower JTC (M = 4.11 draws before decision) than the CG (M = 2.43; Cohen's d = 0.64). No significant difference in the BSPC was observed. DISCUSSION/CONCLUSION Our results indicate that enhancing the sense of body boundaries through a self-massage can reduce an implicit bias associated with delusional ideation and correspondingly support the idea that disembodiment might be a relevant factor in the formation of psychotic symptoms.
Collapse
Affiliation(s)
- Naomi Lyons
- Department for Psychology and Psychotherapy, Witten/Herdecke University, Witten, Germany,
| | - Detlef E Dietrich
- Burghof-Klinik Rinteln, Center for Systems Neuroscience Hannover, Center for Mental Health, Hannover Medical School, Hannover, Germany
| | - Johannes Graser
- Department for Psychology and Psychotherapy, Witten/Herdecke University, Witten, Germany
| | - Georg Juckel
- Psychiatry, Psychotherapy, Psychosomatics, Ruhr-University Bochum, Bochum, Germany
| | - Christian Koßmann
- Psychiatry, Psychotherapy, Psychosomatics, Ruhr-University Bochum, Bochum, Germany
| | | | | | - Johannes Michalak
- Department for Psychology and Psychotherapy, Witten/Herdecke University, Witten, Germany
| |
Collapse
|
12
|
Müller M, Kaegi-Braun N, Schuetz P, Müller B, Kutz A. Association of nutritional support with in-hospital mortality in malnourished medical patients. Clin Nutr ESPEN 2020. [DOI: 10.1016/j.clnesp.2020.09.605] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022]
|
13
|
Hersberger L, Bürgler H, Dietz A, Schuetz P, Müller B, Bargetzi L, Bargetzi A. Individualized nutritional support in congestive heart failure inpatients at nutritional risk secondary analysis of a randomized clinical trial. Clin Nutr ESPEN 2020. [DOI: 10.1016/j.clnesp.2020.09.037] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022]
|
14
|
Bargetzi L, Schütz P, Müller B, Bargetzi M, Brack C, Herrmann J, Bargetzi A, Hersberger L. Association of different cancer types and benefit from nutritional support in patients at nutritional risk: secondary analysis of a prospective randomized trial. Clin Nutr ESPEN 2020. [DOI: 10.1016/j.clnesp.2020.09.460] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
|
15
|
Gronbach M, Mitrach F, Lidzba V, Müller B, Möller S, Rother S, Salbach-Hirsch J, Hofbauer LC, Schnabelrauch M, Hintze V, Hacker MC, Schulz-Siegmund M. Scavenging of Dickkopf-1 by macromer-based biomaterials covalently decorated with sulfated hyaluronan displays pro-osteogenic effects. Acta Biomater 2020; 114:76-89. [PMID: 32673749 DOI: 10.1016/j.actbio.2020.07.017] [Citation(s) in RCA: 10] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/20/2020] [Revised: 06/18/2020] [Accepted: 07/08/2020] [Indexed: 12/27/2022]
Abstract
Dickkopf-1 (DKK1), a Wnt inhibitor secreted by bone marrow stromal cells (MSC), is known to play an important role in long-term non-union bone fracture defects and glucocorticoid induced osteoporosis. Mitigating its effects in early bone defects could improve osteogenesis and bone defect healing. Here, we applied a biomaterial strategy to deplete a defect environment from DKK1 by scavenging the protein via a macromer-based biomaterial covalently decorated with sulfated hyaluronan (sHA3). The material consisted of cross-copolymerized three-armed macromers with a small anchor molecule. Using the glycidyl anchor, polyetheramine (ED900) could be grafted to the material to which sHA3 was efficiently coupled in a separate step. For thorough investigation of material modification, flat material surfaces were generated by fabricating them on glass discs. The binding capability of sHA3 for DKK1 was demonstrated in this study by surface plasmon resonance measurements. Furthermore, the surfaces demonstrated the ability to scavenge and inactivate pathologic amounts of DKK1 from complex media. In a combinatory approach with Wnt3a, we were able to demonstrate that DKK1 is the preferred binding partner of our sHA3-functionalized surfaces. We validated our findings in a complex in vitro setting of differentiating SaOS-2 cells and primary hMSC. Here, endogenous DKK-1 was scavenged resulting in increased osteogenic differentiation indicating that this is a consistent biological effect irrespective of the model system used. Our study provides insights in the mechanisms and efficiency of sHA3 surface functionalization for DKK1 scavenging, which may be used in a clinical context in the future.
Collapse
Affiliation(s)
- M Gronbach
- University of Leipzig, Medical Faculty, Pharmaceutical Technology, Eilenburger Str. 15A, 04317 Leipzig, Germany
| | - F Mitrach
- University of Leipzig, Medical Faculty, Pharmaceutical Technology, Eilenburger Str. 15A, 04317 Leipzig, Germany
| | - V Lidzba
- University of Leipzig, Medical Faculty, Pharmaceutical Technology, Eilenburger Str. 15A, 04317 Leipzig, Germany
| | - B Müller
- University of Leipzig, Medical Faculty, Pharmaceutical Technology, Eilenburger Str. 15A, 04317 Leipzig, Germany
| | - S Möller
- INNOVENT e.V., Biomaterials Department, Pruessingstraße 27B, Jena, Germany
| | - S Rother
- Max Bergmann Center of Biomaterials, Technische Universität Dresden, Budapester Str. 27, 01062 Dresden, Germany
| | - J Salbach-Hirsch
- Department of Medicine III, Technische Universität Dresden, Fetscherstr. 74, 01307 Dresden, Germany
| | - L C Hofbauer
- Department of Medicine III, Technische Universität Dresden, Fetscherstr. 74, 01307 Dresden, Germany; Center for Healthy Aging, Technische Universität Dresden, Fetscherstr. 74, 01307 Dresden, Germany
| | - M Schnabelrauch
- INNOVENT e.V., Biomaterials Department, Pruessingstraße 27B, Jena, Germany
| | - V Hintze
- Max Bergmann Center of Biomaterials, Technische Universität Dresden, Budapester Str. 27, 01062 Dresden, Germany
| | - M C Hacker
- University of Leipzig, Medical Faculty, Pharmaceutical Technology, Eilenburger Str. 15A, 04317 Leipzig, Germany
| | - M Schulz-Siegmund
- University of Leipzig, Medical Faculty, Pharmaceutical Technology, Eilenburger Str. 15A, 04317 Leipzig, Germany.
| |
Collapse
|
16
|
Frey LJ, Vorländer D, Rasch D, Meinen S, Müller B, Mayr T, Dietzel A, Grosch JH, Krull R. Defining mass transfer in a capillary wave micro-bioreactor for dose-response and other cell-based assays. Biochem Eng J 2020. [DOI: 10.1016/j.bej.2020.107667] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/14/2022]
|
17
|
Chan C, Müller B. A Novel multidimensional Boltzmann neutrino transport scheme for core-collapse supernovae. Mon Not R Astron Soc 2020; 496:2000-2020. [PMID: 32624624 PMCID: PMC7324140 DOI: 10.1093/mnras/staa1666] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Received: 03/04/2020] [Revised: 06/09/2020] [Accepted: 06/09/2020] [Indexed: 06/11/2023]
Abstract
We introduce a new discrete-ordinate scheme for solving the general relativistic (GR) Boltzmann transport equation in the context of core-collapse supernovae (CCSNe). Our algorithm avoids the need to spell out the complicated advection terms in energy and angle that arise when the transport equation is formulated in spherical polar coordinates, in the comoving frame, or in a GR space-time. We instead approach the problem by calculating the advection of neutrinos across momentum space using an intuitive particle-like approach that has excellent conservation properties and fully accounts for Lorentz boosts, GR effects, and grid geometry terms. In order to avoid the need for a global implicit solution, time integration is performed using a locally implicit Lax-Wendroff scheme that correctly reproduces the diffusion limit. This will facilitate the use of our method on massively parallel distributed-memory architectures. We have verified the accuracy and stability of our scheme with a suite of test problems in spherical symmetry and axisymmetry. To demonstrate that the new algorithm works stably in CCSN simulations, we have coupled it to the GR hydrodynamics code coconut and present a first demonstration run of a [Formula: see text] progenitor with a reduced set of neutrino opacities.
Collapse
Affiliation(s)
- Conrad Chan
- School of Physics and Astronomy, Monash University, Clayton, VIC 3800, Australia
| | - Bernhard Müller
- School of Physics and Astronomy, Monash University, Clayton, VIC 3800, Australia
| |
Collapse
|
18
|
Martínez-Pérez MJ, Müller B, Lin J, Rodriguez LA, Snoeck E, Kleiner R, Sesé J, Koelle D. Magnetic vortex nucleation and annihilation in bi-stable ultra-small ferromagnetic particles. Nanoscale 2020; 12:2587-2595. [PMID: 31939948 DOI: 10.1039/c9nr08557b] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/10/2023]
Abstract
Vortex-mediated magnetization reversal in individual ultra-small (∼100 nm) ferromagnetic particles at low temperatures is studied by nanoSQUID magnetometry. At zero applied bias field, the flux-closure magnetic state (vortex) and the quasi uniform configuration are bi-stable. This stems from the extremely small size of the nanoparticles that lies very close to the limit of single-domain formation. The analysis of the temperature-dependent (from 0.3 to 70 K) hysteresis of the magnetization allows us to infer the nature of the ground state magnetization configuration. The latter corresponds to a vortex state as also confirmed by electron holography experiments. Based on the simultaneous analysis of the vortex nucleation and annihilation data, we estimate the magnitude of the energy barriers separating the quasi single-domain and the vortex state and their field dependence. For this purpose, we use a modified power-law scaling of the energy barriers as a function of the applied bias field. These studies are essential to test the thermal and temporal stability of flux-closure states stabilized in ultra-small ferromagnets.
Collapse
Affiliation(s)
- M J Martínez-Pérez
- Instituto de Ciencia de Materiales de Aragón and Departamento de Física de la Materia Condensada, CSIC-Universidad de Zaragoza, 50009 Zaragoza, Spain. and Fundación ARAID, Avda. de Ranillas, 50018 Zaragoza, Spain
| | - B Müller
- Physikalisches Institut - Experimentalphysik II and Center for Quantum Science (CQ) in LISA+, Universität Tübingen, Auf der Morgenstelle 14, D-72076 Tübingen, Germany
| | - J Lin
- Physikalisches Institut - Experimentalphysik II and Center for Quantum Science (CQ) in LISA+, Universität Tübingen, Auf der Morgenstelle 14, D-72076 Tübingen, Germany
| | - L A Rodriguez
- Departamento de Física, Universidad del Valle, A.A. 25360, Cali, Colombia and Center of Excellence on Novel Materials - CENM, Universidad del Valle, A.A. 25360, Cali, Colombia
| | - E Snoeck
- CEMES-CNRS 29, rue Jeanne Marvig, B.P. 94347, F-31055 Toulouse Cedex, France
| | - R Kleiner
- Physikalisches Institut - Experimentalphysik II and Center for Quantum Science (CQ) in LISA+, Universität Tübingen, Auf der Morgenstelle 14, D-72076 Tübingen, Germany
| | - J Sesé
- Instituto de Ciencia de Materiales de Aragón and Departamento de Física de la Materia Condensada, CSIC-Universidad de Zaragoza, 50009 Zaragoza, Spain. and Laboratorio de Microscopías Avanzadas (LMA), Instituto de Nanociencia de Aragón (INA), Universidad de Zaragoza, 50018 Zaragoza, Spain
| | - D Koelle
- Physikalisches Institut - Experimentalphysik II and Center for Quantum Science (CQ) in LISA+, Universität Tübingen, Auf der Morgenstelle 14, D-72076 Tübingen, Germany
| |
Collapse
|
19
|
Brandes K, Leuzinger K, Rogge G, Müller B, Teifke J. Conjunctival Papillomas and Corneal Squamous Cell Carcinomas After Long-term Ciclosporin Treatment in Four Brachycephalic Dogs with Chronic Keratitis. J Comp Pathol 2020. [DOI: 10.1016/j.jcpa.2019.10.188] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
|
20
|
McCarthy K, Hischenhuber C, Joyce N, Cherix G, Hischenhuber C, Joyce N, Kuhr S, McDonald J, McKnight S, McNamee P, Mevissen L, Müller B, Revitt S. Determination of Total Taurine in Pet Foods by Liquid Chromatography of the Dansyl Derivative: Collaborative Study. J AOAC Int 2019. [DOI: 10.1093/jaoac/83.4.784] [Citation(s) in RCA: 9] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022]
Abstract
Abstract
A liquid chromatographic (LC) method for the determination of total taurine in pet foods was evaluated in a collaborative study. Ten laboratories assayed 6 blind duplicate pairs of wet and dry pet foods. The taurine in the 6 sample pairs ranged from low (170 mg/kg) to high (2250 mg/kg) concentrations as is. Collaborators also assayed a sample of known taurine concentration for familiarization purposes. Samples were hydrolyzed to release bound taurine, which was subsequently converted to the dansyl derivative and quantitated by gradient-elution LC with fluorescence detection. Repeatability relative standard deviations, RSDr, ranged from 3.2 to 10.0%; reproducibility relative standard deviations, RSDR, ranged from 6.1 to 16.1%. The method has been adopted Official First Action status by AOAC INTERNATIONAL.
Collapse
Affiliation(s)
- Kieran McCarthy
- Pedigree Masterfoods, Mill St, Melton Mowbray, Leicestershire, LE13 1BB, United Kingdom
| | | | - Neil Joyce
- Eclipse Scientific Group, Aspland & James House, Medcalfe Way, Bridge St, Chatteris, Cambs, PE16 6QZ, United Kingdom
| | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
21
|
Torres-Forné A, Cerdá-Durán P, Obergaulinger M, Müller B, Font JA. Universal Relations for Gravitational-Wave Asteroseismology of Protoneutron Stars. Phys Rev Lett 2019; 123:051102. [PMID: 31491293 DOI: 10.1103/physrevlett.123.051102] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 02/27/2019] [Indexed: 06/10/2023]
Abstract
State-of-the-art numerical simulations of core-collapse supernovae reveal that the main source of gravitational waves is the excitation of protoneutron star modes during postbounce evolution. In this work we derive universal relations that relate the frequencies of the most common oscillation modes observed, i.e., g modes, p modes, and the f mode, with fundamental properties of the system, such as the surface gravity of the protoneutron star or the mean density in the region enclosed by the shock. These relations are independent of the equation of state, the neutrino treatment, and the progenitor mass and, hence, can be used to build methods to infer protoneutron star properties from gravitational-wave observations alone. We outline how these measurements could be done and the constraints that could be placed on the protoneutron star properties.
Collapse
Affiliation(s)
- Alejandro Torres-Forné
- Max Planck Institute for Gravitational Physics (Albert Einstein Institute), D-14476 Potsdam-Golm, Germany
| | - Pablo Cerdá-Durán
- Departamento de Astronomía y Astrofísica, Universitat de València, Dr. Moliner 50, 46100 Burjassot, Spain
| | - Martin Obergaulinger
- Departamento de Astronomía y Astrofísica, Universitat de València, Dr. Moliner 50, 46100 Burjassot, Spain
- Institut fur Kernphysik, Theoriezentrum, Schlossgartenstrasse 2, D-64289 Darmstadt, Germany
| | - Bernhard Müller
- Monash Centre for Astrophysics, School of Physics and Astronomy, Monash University, Clayton, Victoria 3800, Australia
| | - José A Font
- Departamento de Astronomía y Astrofísica, Universitat de València, Dr. Moliner 50, 46100 Burjassot, Spain
- Observatori Astronòmic, Universitat de València, José Beltrán 2, 46980 Paterna, Spain
| |
Collapse
|
22
|
Frey LJ, Vorländer D, Rasch D, Ostsieker H, Müller B, Schulze M, Schenkendorf R, Mayr T, Grosch JH, Krull R. Novel electrodynamic oscillation technique enables enhanced mass transfer and mixing for cultivation in micro-bioreactor. Biotechnol Prog 2019; 35:e2827. [PMID: 31021498 DOI: 10.1002/btpr.2827] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/31/2019] [Revised: 03/21/2019] [Accepted: 04/19/2019] [Indexed: 12/23/2022]
Abstract
Micro-bioreactors (MBRs) have become an indispensable part for modern bioprocess development enabling automated experiments in parallel while reducing material cost. Novel developments aim to further intensify the advantages as dimensions are being reduced. However, one factor hindering the scale-down of cultivation systems is to provide adequate mixing and mass transfer. Here, vertical oscillation is demonstrated as an effective method for mixing of MBRs with a reaction volume of 20 μL providing adequate mass transfer. Electrodynamic exciters are used to transduce kinetic energy onto the cultivation broth avoiding additional moving parts inside the applied model MBR. The induced vertical vibration leads to oscillation of the liquid surface corresponding to the frequency and displacement. On this basis, the resonance frequency of the fluid was identified as the most decisive factor for mixing performance. Applying this vertical oscillation method outstanding mixing times below 1 s and exceptionally high oxygen transport with volumetric mass transfer coefficients (kL a) above 1,000/hr can be successfully achieved and controlled. To evaluate the applicability of this vertical oscillation mixing for low volume MBR systems, cultivations of Escherichia coli BL21 as proof-of-concept were performed. The dissolved oxygen was successfully online monitored to assure any avoidance of oxygen limitations during the cultivation. The here presented data illustrate the high potential of the vertical oscillation technique as a flexible measure to adapt mixing times and oxygen transfer according to experimental demands. Thus, the mixing technique is a promising tool for various biological and chemical micro-scale applications still enabling adequate mass transfer.
Collapse
Affiliation(s)
- Lasse J Frey
- Institute of Biochemical Engineering, Technische Universität Braunschweig, Braunschweig, Germany.,Center of Pharmaceutical Engineering (PVZ), Technische Universität Braunschweig, Braunschweig, Germany
| | - David Vorländer
- Institute of Biochemical Engineering, Technische Universität Braunschweig, Braunschweig, Germany.,Center of Pharmaceutical Engineering (PVZ), Technische Universität Braunschweig, Braunschweig, Germany
| | - Detlev Rasch
- Institute of Biochemical Engineering, Technische Universität Braunschweig, Braunschweig, Germany.,Center of Pharmaceutical Engineering (PVZ), Technische Universität Braunschweig, Braunschweig, Germany
| | - Hendrik Ostsieker
- Institute of Biochemical Engineering, Technische Universität Braunschweig, Braunschweig, Germany.,Center of Pharmaceutical Engineering (PVZ), Technische Universität Braunschweig, Braunschweig, Germany
| | - Bernhard Müller
- Institute of Analytical Chemistry and Food Chemistry, Graz University of Technologies, Graz, Austria
| | - Moritz Schulze
- Center of Pharmaceutical Engineering (PVZ), Technische Universität Braunschweig, Braunschweig, Germany.,Institute of Energy and Process Systems Engineering, Technische Universität Braunschweig, Braunschweig, Germany
| | - René Schenkendorf
- Center of Pharmaceutical Engineering (PVZ), Technische Universität Braunschweig, Braunschweig, Germany.,Institute of Energy and Process Systems Engineering, Technische Universität Braunschweig, Braunschweig, Germany
| | - Torsten Mayr
- Institute of Analytical Chemistry and Food Chemistry, Graz University of Technologies, Graz, Austria
| | - Jan-Hendrik Grosch
- Institute of Biochemical Engineering, Technische Universität Braunschweig, Braunschweig, Germany.,Center of Pharmaceutical Engineering (PVZ), Technische Universität Braunschweig, Braunschweig, Germany
| | - Rainer Krull
- Institute of Biochemical Engineering, Technische Universität Braunschweig, Braunschweig, Germany.,Center of Pharmaceutical Engineering (PVZ), Technische Universität Braunschweig, Braunschweig, Germany
| |
Collapse
|
23
|
Knopp C, Häusler M, Müller B, Damen R, Stoppe A, Mull M, Elbracht M, Kurth I, Begemann M. PDE10A mutation in two sisters with a hyperkinetic movement disorder - Response to levodopa. Parkinsonism Relat Disord 2019; 63:240-242. [PMID: 30777652 DOI: 10.1016/j.parkreldis.2019.02.007] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 10/01/2018] [Revised: 02/07/2019] [Accepted: 02/08/2019] [Indexed: 12/12/2022]
Affiliation(s)
- C Knopp
- Institute of Human Genetics, Medical Faculty, RWTH Aachen University, Pauwelsstr. 30, 52074, Aachen, Germany.
| | - M Häusler
- Division of Neuropediatrics and Social Pediatrics, Department of Pediatrics, Medical Faculty, RWTH Aachen University, Pauwelsstr. 30, 52074 Aachen, Germany
| | - B Müller
- Division of Neuropediatrics and Social Pediatrics, Department of Pediatrics, Medical Faculty, RWTH Aachen University, Pauwelsstr. 30, 52074 Aachen, Germany
| | - R Damen
- Division of Neuropediatrics and Social Pediatrics, Department of Pediatrics, Medical Faculty, RWTH Aachen University, Pauwelsstr. 30, 52074 Aachen, Germany
| | - A Stoppe
- Division of Neuropediatrics and Social Pediatrics, Department of Pediatrics, Medical Faculty, RWTH Aachen University, Pauwelsstr. 30, 52074 Aachen, Germany
| | - M Mull
- Department of Diagnostic and Interventional Neuroradiology, Medical Faculty, RWTH Aachen University, Pauwelsstr. 30, 52074 Aachen, Germany
| | - M Elbracht
- Institute of Human Genetics, Medical Faculty, RWTH Aachen University, Pauwelsstr. 30, 52074 Aachen, Germany
| | - I Kurth
- Institute of Human Genetics, Medical Faculty, RWTH Aachen University, Pauwelsstr. 30, 52074 Aachen, Germany
| | - M Begemann
- Institute of Human Genetics, Medical Faculty, RWTH Aachen University, Pauwelsstr. 30, 52074 Aachen, Germany
| |
Collapse
|
24
|
Schlegel J, Hoffmann J, Röll D, Müller B, Günther S, Zhang W, Janise A, Vössing C, Fühler B, Neidhardt J, Khanna H, Lorenz B, Stieger K. Toward genome editing in X-linked RP-development of a mouse model with specific treatment relevant features. Transl Res 2019; 203:57-72. [PMID: 30213530 PMCID: PMC6294733 DOI: 10.1016/j.trsl.2018.08.006] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 11/22/2017] [Revised: 08/16/2018] [Accepted: 08/16/2018] [Indexed: 01/06/2023]
Abstract
Genome editing represents a powerful tool to treat inherited disorders. Highly specific endonucleases induce a DNA double strand break near the mutant site, which is subsequently repaired by cellular DNA repair mechanisms that involve the presence of a wild type template DNA. In vivo applications of this strategy are still rare, in part due to the absence of appropriate animal models carrying human disease mutations and knowledge of the efficient targeting of endonucleases. Here we report the generation and characterization of a new mouse model for X-linked retinitis pigmentosa (XLRP) carrying a point mutation in the mutational hotspot exon ORF15 of the RPGR gene as well as a recognition site for the homing endonuclease I-SceI. Presence of the genomic modifications was verified at the RNA and protein levels. The mutant protein was observed at low levels. Optical coherence tomography studies revealed a slowly progressive retinal degeneration with photoreceptor loss starting at 9 months of age, paralleling the onset of functional deficits as seen in the electroretinogram. Early changes to the outer retinal bands can be used as biomarker during treatment applications. We further show for the first time efficient targeting using the I-SceI enzyme at the genomic locus in a proof of concept in photoreceptors following adeno-associated virus mediated gene transfer in vivo. Taken together, our studies not only provide a human-XLRP disease model but also act as a platform to design genome editing technology for retinal degenerative diseases using the currently available endonucleases.
Collapse
Affiliation(s)
- J Schlegel
- Department of Ophthalmology, Faculty of Medicine, Justus-Liebig-University Giessen, Giessen, Germany
| | - J Hoffmann
- Department of Ophthalmology, Faculty of Medicine, Justus-Liebig-University Giessen, Giessen, Germany
| | - D Röll
- Department of Ophthalmology, Faculty of Medicine, Justus-Liebig-University Giessen, Giessen, Germany
| | - B Müller
- Department of Ophthalmology, Faculty of Medicine, Justus-Liebig-University Giessen, Giessen, Germany
| | - S Günther
- Max-Planck-Institute for Heart and Lung Research, Bad Nauheim, Germany
| | - W Zhang
- Department of Ophthalmology, University of Massachusetts Medical School, Worcester, Massachusetts
| | - A Janise
- Department of Ophthalmology, Faculty of Medicine, Justus-Liebig-University Giessen, Giessen, Germany
| | - C Vössing
- Human Genetics, Faculty of Medicine and Health Sciences, University of Oldenburg, Oldenburg, Germany
| | - B Fühler
- Department of Ophthalmology, Faculty of Medicine, Justus-Liebig-University Giessen, Giessen, Germany
| | - J Neidhardt
- Human Genetics, Faculty of Medicine and Health Sciences, University of Oldenburg, Oldenburg, Germany; Research Center Neurosensory Science, University Oldenburg, Oldenburg, Germany
| | - H Khanna
- Department of Ophthalmology, University of Massachusetts Medical School, Worcester, Massachusetts
| | - B Lorenz
- Department of Ophthalmology, Faculty of Medicine, Justus-Liebig-University Giessen, Giessen, Germany
| | - K Stieger
- Department of Ophthalmology, Faculty of Medicine, Justus-Liebig-University Giessen, Giessen, Germany.
| |
Collapse
|
25
|
Hien A, Pretze M, Braun F, Schäfer E, Kümmel T, Roscher M, Schock-Kusch D, Waldeck J, Müller B, Wängler C, Rädle M, Wängler B. Noncontact recognition of fluorescently labeled objects in deep tissue via a novel optical light beam arrangement. PLoS One 2018; 13:e0208236. [PMID: 30566459 PMCID: PMC6300195 DOI: 10.1371/journal.pone.0208236] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/16/2018] [Accepted: 11/14/2018] [Indexed: 12/30/2022] Open
Abstract
To date, few optical imaging systems are available in clinical practice to perform noninvasive measurements transcutaneously. Instead, functional imaging is performed using ionizing radiation or intense magnetic fields in most cases. The applicability of fluorescence imaging (e.g., for the detection of fluorescently labeled objects, such as tumors) is limited due to the restricted tissue penetration of light and the required long exposure time. Thus, the development of highly sensitive and easily manageable instruments is necessary to broaden the utility of optical imaging. To advance these developments, an improved fluorescence imaging system was designed in this study that operates on the principle of noncontact laser-induced fluorescence and enables the detection of fluorescence from deeper tissue layers as well as real-time imaging. The high performance of the developed optical laser scanner results from the combination of specific point illumination, an intensified charge-coupled device (ICCD) detector with a novel light trap, and a filtering strategy. The suitability of the laser scanner was demonstrated in two representative applications and an in vivo evaluation. In addition, a comparison with a planar imaging system was performed. The results show that the exposure time with the developed laser scanner can be reduced to a few milliseconds during measurements with a penetration depth of up to 32 mm. Due to these short exposure times, real-time fluorescence imaging can be easily achieved. The ability to measure fluorescence from deep tissue layers enables clinically relevant applications, such as the detection of fluorescently labeled malignant tumors.
Collapse
Affiliation(s)
- Andreas Hien
- Institute of Process Control and Innovative Energy Conversion, Mannheim University of Applied Sciences, Mannheim, Germany
- * E-mail:
| | - Marc Pretze
- Molecular Imaging and Radiochemistry, Department of Clinical Radiology and Nuclear Medicine, Medical Faculty Mannheim of Heidelberg University, Mannheim, Germany
| | - Frank Braun
- Institute of Process Control and Innovative Energy Conversion, Mannheim University of Applied Sciences, Mannheim, Germany
| | - Edgar Schäfer
- Institute of Process Control and Innovative Energy Conversion, Mannheim University of Applied Sciences, Mannheim, Germany
| | - Tim Kümmel
- Institute of Process Control and Innovative Energy Conversion, Mannheim University of Applied Sciences, Mannheim, Germany
| | - Mareike Roscher
- Molecular Imaging and Radiochemistry, Department of Clinical Radiology and Nuclear Medicine, Medical Faculty Mannheim of Heidelberg University, Mannheim, Germany
| | - Daniel Schock-Kusch
- Institute of Process Control and Innovative Energy Conversion, Mannheim University of Applied Sciences, Mannheim, Germany
| | | | | | - Carmen Wängler
- Biomedical Chemistry, Department of Clinical Radiology and Nuclear Medicine, Medical Faculty Mannheim of Heidelberg University, Mannheim, Germany
| | - Matthias Rädle
- Institute of Process Control and Innovative Energy Conversion, Mannheim University of Applied Sciences, Mannheim, Germany
| | - Björn Wängler
- Molecular Imaging and Radiochemistry, Department of Clinical Radiology and Nuclear Medicine, Medical Faculty Mannheim of Heidelberg University, Mannheim, Germany
| |
Collapse
|
26
|
Martínez-Pérez MJ, Pablo-Navarro J, Müller B, Kleiner R, Magén C, Koelle D, de Teresa JM, Sesé J. NanoSQUID Magnetometry on Individual As-grown and Annealed Co Nanowires at Variable Temperature. Nano Lett 2018; 18:7674-7682. [PMID: 30458106 DOI: 10.1021/acs.nanolett.8b03329] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/09/2023]
Abstract
Performing magnetization studies on individual nanoparticles is a highly demanding task, especially when measurements need to be carried out under large sweeping magnetic fields or variable temperature. Yet, characterization under varying ambient conditions is paramount in order to fully understand the magnetic behavior of these objects, e.g., the formation of nonuniform states or the mechanisms leading to magnetization reversal and thermal stability. This, in turn, is necessary for the integration of magnetic nanoparticles and nanowires into useful devices, e.g., spin-valves, racetrack memories, or magnetic tip probes. Here, we show that nanosuperconducting quantum interference devices based on high critical temperature superconductors are particularly well suited for this task. We have successfully characterized a number of individual Co nanowires grown through focused electron beam induced deposition and subsequently annealed at different temperatures. Magnetization measurements performed under sweeping magnetic fields (up to ∼100 mT) and variable temperature (1.4-80 K) underscore the intrinsic structural and chemical differences between these nanowires. These point to significant changes in the crystalline structure and the resulting effective magnetic anisotropy of the nanowires, and to the nucleation and subsequent vanishing of antiferromagnetic species within the nanowires annealed at different temperatures.
Collapse
Affiliation(s)
- M J Martínez-Pérez
- Instituto de Ciencia de Materiales de Aragón and Departamento de Física de la Materia Condensada , CSIC-Universidad de Zaragoza , 50009 Zaragoza , Spain
- Fundación ARAID , 50018 Zaragoza , Spain
| | - J Pablo-Navarro
- Laboratorio de Microscopías Avanzadas (LMA), Instituto de Nanociencia de Aragón (INA) , Universidad de Zaragoza , 50018 Zaragoza , Spain
| | - B Müller
- Physikalisches Institut, Experimentalphysik II and Center for Quantum Science (CQ) in LISA+ , Universität Tübingen , 72076 Tübingen , Germany
| | - R Kleiner
- Physikalisches Institut, Experimentalphysik II and Center for Quantum Science (CQ) in LISA+ , Universität Tübingen , 72076 Tübingen , Germany
| | - C Magén
- Instituto de Ciencia de Materiales de Aragón and Departamento de Física de la Materia Condensada , CSIC-Universidad de Zaragoza , 50009 Zaragoza , Spain
- Laboratorio de Microscopías Avanzadas (LMA), Instituto de Nanociencia de Aragón (INA) , Universidad de Zaragoza , 50018 Zaragoza , Spain
| | - D Koelle
- Physikalisches Institut, Experimentalphysik II and Center for Quantum Science (CQ) in LISA+ , Universität Tübingen , 72076 Tübingen , Germany
| | - J M de Teresa
- Instituto de Ciencia de Materiales de Aragón and Departamento de Física de la Materia Condensada , CSIC-Universidad de Zaragoza , 50009 Zaragoza , Spain
- Laboratorio de Microscopías Avanzadas (LMA), Instituto de Nanociencia de Aragón (INA) , Universidad de Zaragoza , 50018 Zaragoza , Spain
| | - J Sesé
- Instituto de Ciencia de Materiales de Aragón and Departamento de Física de la Materia Condensada , CSIC-Universidad de Zaragoza , 50009 Zaragoza , Spain
- Laboratorio de Microscopías Avanzadas (LMA), Instituto de Nanociencia de Aragón (INA) , Universidad de Zaragoza , 50018 Zaragoza , Spain
| |
Collapse
|
27
|
Verhaelen K, Bauer A, Günther F, Müller B, Nist M, Ülker Celik B, Weidner C, Küchenhoff H, Wallner P. Anticipation of food safety and fraud issues: ISAR - A new screening tool to monitor food prices and commodity flows. Food Control 2018. [DOI: 10.1016/j.foodcont.2018.06.029] [Citation(s) in RCA: 14] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/11/2023]
|
28
|
Müller B, Grengg C, Schallert V, Sakoparnig M, Staudinger C, Breininger J, Mittermayr F, Ungerböck B, Borisov SM, Dietzel M, Mayr T. Wide-range optical pH imaging of cementitious materials exposed to chemically corrosive environments. RILEM Tech Lett 2018. [DOI: 10.21809/rilemtechlett.2018.72] [Citation(s) in RCA: 8] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 12/01/2022]
Abstract
The pH of concrete-based material is a key parameter for the assessment of its stability and durability, since a change in pH is usually associated with major types of chemical degradation such as carbonation, leaching and acid attacks. Conventional surface pH measurements with potentiometric flat surface electrodes have low spatial resolution, whereas optical pH visualization with indicator dyes (phenolphthalein) only indicates the areas with higher or lower pH than the pKa of the indicator. In this regard, it is key to develop wide-range imaging systems, enabling accurate and spatially resolved determination of pH variability for an advanced knowledge of degradation mechanisms. This contribution presents the enhancements made for a high-resolution optical pH imaging system based on fluorescent aza-BODIPY indicator dyes. The measurement range was increased to 6 pH units (pH 6.5 to pH 12.5) by a combination of two indicator dyes. Moreover, background scattering effects were sufficiently eliminated. With the improved sensor foils steep pH gradients (up to 3 pH units within 2 mm) were successfully recorded in various concrete specimens using a macro lens reaching a resolution of down to 35 µm per pixel.
Collapse
|
29
|
Khodadad D, Nordebo S, Müller B, Waldmann A, Yerworth R, Becher T, Frerichs I, Sophocleous L, van Kaam A, Miedema M, Seifnaraghi N, Bayford R. Optimized breath detection algorithm in electrical impedance tomography. Physiol Meas 2018; 39:094001. [PMID: 30074906 DOI: 10.1088/1361-6579/aad7e6] [Citation(s) in RCA: 18] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/21/2022]
Abstract
OBJECTIVE This paper defines a method for optimizing the breath delineation algorithms used in electrical impedance tomography (EIT). In lung EIT the identification of the breath phases is central for generating tidal impedance variation images, subsequent data analysis and clinical evaluation. The optimisation of these algorithms is particularly important in neonatal care since the existing breath detectors developed for adults may give insufficient reliability in neonates due to their very irregular breathing pattern. APPROACH Our approach is generic in the sense that it relies on the definition of a gold standard and the associated definition of detector sensitivity and specificity, an optimisation criterion and a set of detector parameters to be investigated. The gold standard has been defined by 11 clinicians with previous experience with EIT and the performance of our approach is described and validated using a neonatal EIT dataset acquired within the EU-funded CRADL project. MAIN RESULTS Three different algorithms are proposed that improve the breath detector performance by adding conditions on (1) maximum tidal breath rate obtained from zero-crossings of the EIT breathing signal, (2) minimum tidal impedance amplitude and (3) minimum tidal breath rate obtained from time-frequency analysis. As a baseline a zero-crossing algorithm has been used with some default parameters based on the Swisstom EIT device. SIGNIFICANCE Based on the gold standard, the most crucial parameters of the proposed algorithms are optimised by using a simple exhaustive search and a weighted metric defined in connection with the receiver operating characterics. This provides a practical way to achieve any desirable trade-off between the sensitivity and the specificity of the detectors.
Collapse
Affiliation(s)
- D Khodadad
- Department of Physics and Electrical Engineering, Linnaeus University, Växjö, Sweden
| | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
30
|
Leonhardt T, Skula J, Müller B, Schulthess P, Jeisy J, Riedl W. (Semi)-Kontinuierliche Synthese von Produkten für die Pharma- oder Feinchemie in einem neuartigen Rohrreaktor im Pilotmaßstab. CHEM-ING-TECH 2018. [DOI: 10.1002/cite.201855215] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/11/2022]
Affiliation(s)
- T. Leonhardt
- Fachhochschule Nordwestschweiz, Hochschule für Life Sciences; Institut für Chemie und Bioanalytik; Hofackerstraße 30 4132 Muttenz Schweiz
| | - J. Skula
- Fachhochschule Nordwestschweiz, Hochschule für Life Sciences; Institut für Chemie und Bioanalytik; Hofackerstraße 30 4132 Muttenz Schweiz
| | - B. Müller
- Fachhochschule Nordwestschweiz, Hochschule für Life Sciences; Institut für Chemie und Bioanalytik; Hofackerstraße 30 4132 Muttenz Schweiz
| | - P. Schulthess
- Fachhochschule Nordwestschweiz, Hochschule für Life Sciences; Institut für Chemie und Bioanalytik; Hofackerstraße 30 4132 Muttenz Schweiz
| | - J. Jeisy
- eh. F. Hoffmann-La Roche AG; Hauptstraße 54 4148 Pfeffingen Schweiz
| | - W. Riedl
- Fachhochschule Nordwestschweiz, Hochschule für Life Sciences; Institut für Chemie und Bioanalytik; Hofackerstraße 30 4132 Muttenz Schweiz
| |
Collapse
|
31
|
Meyer B, Keller A, Wöhlbier HG, Müller B, Kropp P. Progressive Muskelrelaxation nach Jacobson reduziert die Anzahl der Migränetage und normalisiert Amplituden bei der Messung der contingent negative variation. Psychother Psychosom Med Psychol 2018. [DOI: 10.1055/s-0038-1668017] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/28/2022]
Affiliation(s)
- B Meyer
- Universitätsmedizin Rostock, Zentrum Nervenheilkunde, Institut für Medizinische Psychologie und Medizinische Soziologie, Rostock, Deutschland
| | - A Keller
- Universitätsmedizin Rostock, Zentrum Nervenheilkunde, Institut für Medizinische Psychologie und Medizinische Soziologie, Rostock, Deutschland
| | - HG Wöhlbier
- Universitätsmedizin Rostock, Zentrum Nervenheilkunde, Institut für Medizinische Psychologie und Medizinische Soziologie, Rostock, Deutschland
| | - B Müller
- Universitätsmedizin Rostock, Zentrum Nervenheilkunde, Institut für Medizinische Psychologie und Medizinische Soziologie, Rostock, Deutschland
| | - P Kropp
- Universitätsmedizin Rostock, Zentrum Nervenheilkunde, Institut für Medizinische Psychologie und Medizinische Soziologie, Rostock, Deutschland
| |
Collapse
|
32
|
Lüpke J, Müller B, Meyer B, Müller-Hilke B, Kropp P. Validierung einer OSCE-Station zur Medizinischen Psychologie und Medizinischen Soziologie durch einen Empathie-Fragebogen. Psychother Psychosom Med Psychol 2018. [DOI: 10.1055/s-0038-1668037] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/28/2022]
Affiliation(s)
- J Lüpke
- Universitätsmedizin Rostock, Institut für Medizinische Psychologie und Medizinische Soziologie, Rostock, Deutschland
| | - B Müller
- Universitätsmedizin Rostock, Institut für Medizinische Psychologie und Medizinische Soziologie, Rostock, Deutschland
| | - B Meyer
- Universitätsmedizin Rostock, Institut für Medizinische Psychologie und Medizinische Soziologie, Rostock, Deutschland
| | - B Müller-Hilke
- Universitätsmedizin Rostock, Institut für Immunologie, Rostock, Deutschland
| | - P Kropp
- Universitätsmedizin Rostock, Zentrum Nervenheilkunde, Institut für Medizinische Psychologie und Medizinische Soziologie, Rostock, Deutschland
| |
Collapse
|
33
|
Zirath H, Rothbauer M, Spitz S, Bachmann B, Jordan C, Müller B, Ehgartner J, Priglinger E, Mühleder S, Redl H, Holnthoner W, Harasek M, Mayr T, Ertl P. Every Breath You Take: Non-invasive Real-Time Oxygen Biosensing in Two- and Three-Dimensional Microfluidic Cell Models. Front Physiol 2018; 9:815. [PMID: 30018569 PMCID: PMC6037982 DOI: 10.3389/fphys.2018.00815] [Citation(s) in RCA: 53] [Impact Index Per Article: 8.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/12/2018] [Accepted: 06/11/2018] [Indexed: 01/08/2023] Open
Abstract
Knowledge on the availability of dissolved oxygen inside microfluidic cell culture systems is vital for recreating physiological-relevant microenvironments and for providing reliable and reproducible measurement conditions. It is important to highlight that in vivo cells experience a diverse range of oxygen tensions depending on the resident tissue type, which can also be recreated in vitro using specialized cell culture instruments that regulate external oxygen concentrations. While cell-culture conditions can be readily adjusted using state-of-the-art incubators, the control of physiological-relevant microenvironments within the microfluidic chip, however, requires the integration of oxygen sensors. Although several sensing approaches have been reported to monitor oxygen levels in the presence of cell monolayers, oxygen demands of microfluidic three-dimensional (3D)-cell cultures and spatio-temporal variations of oxygen concentrations inside two-dimensional (2D) and 3D cell culture systems are still largely unknown. To gain a better understanding on available oxygen levels inside organ-on-a-chip systems, we have therefore developed two different microfluidic devices containing embedded sensor arrays to monitor local oxygen levels to investigate (i) oxygen consumption rates of 2D and 3D hydrogel-based cell cultures, (ii) the establishment of oxygen gradients within cell culture chambers, and (iii) influence of microfluidic material (e.g., gas tight vs. gas permeable), surface coatings, cell densities, and medium flow rate on the respiratory activities of four different cell types. We demonstrate how dynamic control of cyclic normoxic-hypoxic cell microenvironments can be readily accomplished using programmable flow profiles employing both gas-impermeable and gas-permeable microfluidic biochips.
Collapse
Affiliation(s)
- Helene Zirath
- Institute of Applied Synthetic Chemistry, Institute of Chemical Technologies and Analytics, Institute of Chemical, Environmental and Bioscience Engineering, Vienna University of Technology, Vienna, Austria.,Austrian Cluster for Tissue Regeneration, Vienna, Austria
| | - Mario Rothbauer
- Institute of Applied Synthetic Chemistry, Institute of Chemical Technologies and Analytics, Institute of Chemical, Environmental and Bioscience Engineering, Vienna University of Technology, Vienna, Austria.,Austrian Cluster for Tissue Regeneration, Vienna, Austria
| | - Sarah Spitz
- Institute of Applied Synthetic Chemistry, Institute of Chemical Technologies and Analytics, Institute of Chemical, Environmental and Bioscience Engineering, Vienna University of Technology, Vienna, Austria.,Austrian Cluster for Tissue Regeneration, Vienna, Austria
| | - Barbara Bachmann
- Institute of Applied Synthetic Chemistry, Institute of Chemical Technologies and Analytics, Institute of Chemical, Environmental and Bioscience Engineering, Vienna University of Technology, Vienna, Austria.,Austrian Cluster for Tissue Regeneration, Vienna, Austria.,Ludwig Boltzmann Institute for Experimental and Clinical Traumatology, Allgemeine Unfallversicherungsanstalt (AUVA) Research Centre, Vienna, Austria
| | - Christian Jordan
- Institute of Applied Synthetic Chemistry, Institute of Chemical Technologies and Analytics, Institute of Chemical, Environmental and Bioscience Engineering, Vienna University of Technology, Vienna, Austria
| | - Bernhard Müller
- Institute of Analytical Chemistry and Food Chemistry, Graz University of Technology, NAWI Graz, Graz, Austria
| | - Josef Ehgartner
- Institute of Analytical Chemistry and Food Chemistry, Graz University of Technology, NAWI Graz, Graz, Austria
| | - Eleni Priglinger
- Austrian Cluster for Tissue Regeneration, Vienna, Austria.,Ludwig Boltzmann Institute for Experimental and Clinical Traumatology, Allgemeine Unfallversicherungsanstalt (AUVA) Research Centre, Vienna, Austria
| | - Severin Mühleder
- Austrian Cluster for Tissue Regeneration, Vienna, Austria.,Ludwig Boltzmann Institute for Experimental and Clinical Traumatology, Allgemeine Unfallversicherungsanstalt (AUVA) Research Centre, Vienna, Austria
| | - Heinz Redl
- Austrian Cluster for Tissue Regeneration, Vienna, Austria.,Ludwig Boltzmann Institute for Experimental and Clinical Traumatology, Allgemeine Unfallversicherungsanstalt (AUVA) Research Centre, Vienna, Austria
| | - Wolfgang Holnthoner
- Austrian Cluster for Tissue Regeneration, Vienna, Austria.,Ludwig Boltzmann Institute for Experimental and Clinical Traumatology, Allgemeine Unfallversicherungsanstalt (AUVA) Research Centre, Vienna, Austria
| | - Michael Harasek
- Institute of Applied Synthetic Chemistry, Institute of Chemical Technologies and Analytics, Institute of Chemical, Environmental and Bioscience Engineering, Vienna University of Technology, Vienna, Austria
| | - Torsten Mayr
- Institute of Analytical Chemistry and Food Chemistry, Graz University of Technology, NAWI Graz, Graz, Austria
| | - Peter Ertl
- Institute of Applied Synthetic Chemistry, Institute of Chemical Technologies and Analytics, Institute of Chemical, Environmental and Bioscience Engineering, Vienna University of Technology, Vienna, Austria.,Austrian Cluster for Tissue Regeneration, Vienna, Austria
| |
Collapse
|
34
|
Abstract
Autoclave manufacturing of fibre metal laminates, such as GLARE, is an expensive process. Therefore, there is an increasing interest to find cost-effective out-of-autoclave manufacturing processes without diminishing the laminate quality. The aim of this study is to evaluate the quality of fibre metal laminate panels adhesively bonded and cured using resistance heating. Three manufacturing processes are compared for different layups with an embedded steel mesh at the mid-plane: autoclave curing, resistance bonding of two (autoclave-cured) panels and complete out-of-autoclave resistance curing of panels. Interlaminar shear strength tests and optical microscopy analysis showed that resistance bonding is a promising technique, leading to results comparable to autoclave curing. Resistance curing led to an interlaminar shear strength decrease of 30-60%. A study of the correlation between degree of cure and distance from the mesh revealed the potential of resistance bonding to be used for flexible embedded mesh geometries and on-site repairs.
Collapse
Affiliation(s)
| | | | - Sofia Teixeira De Freitas
- Sofia Teixeira De Freitas, Faculty of Aerospace Engineering, Delft University of Technology, Klyverweg 1, 2629 HS Delft, The Netherlands.
| | | |
Collapse
|
35
|
Zemskaya TI, Lomakina AV, Mamaeva EV, Zakharenko AS, Likhoshvai AV, Galach’yants YP, Müller B. Composition of Microbial Communities in Sediments from Southern Baikal Containing Fe/Mn Concretions. Microbiology (Reading) 2018. [DOI: 10.1134/s0026261718030165] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/22/2022] Open
|
36
|
Abstract
Localizing a histological section in the three-dimensional dataset of a different imaging modality is a challenging 2D-3D registration problem. In the literature, several approaches have been proposed to solve this problem; however, they cannot be considered as fully automatic. Recently, we developed an automatic algorithm that could successfully find the position of a histological section in a micro computed tomography (μCT) volume. For the majority of the datasets, the result of localization corresponded to the manual results. However, for some datasets, the matching μCT slice was off the ground-truth position. Furthermore, elastic distortions, due to histological preparation, could not be accounted for in this framework. In the current study, we introduce two optimization frameworks based on normalized mutual information, which enabled us to accurately register histology slides to volume data. The rigid approach allocated 81 % of histological sections with a median position error of 8.4 μm in jaw bone datasets, and the deformable approach improved registration by 33 μm with respect to the median distance error for four histological slides in the cerebellum dataset.
Collapse
Affiliation(s)
- N Chicherova
- Center for medical Image Analysis & Navigation, Department of Biomedical Engineering, University of Basel, Allschwil, Switzerland.,Biomaterials Science Center, Department of Biomedical Engineering, University of Basel, Allschwil, Switzerland
| | - S E Hieber
- Biomaterials Science Center, Department of Biomedical Engineering, University of Basel, Allschwil, Switzerland
| | - A Khimchenko
- Biomaterials Science Center, Department of Biomedical Engineering, University of Basel, Allschwil, Switzerland
| | - C Bikis
- Biomaterials Science Center, Department of Biomedical Engineering, University of Basel, Allschwil, Switzerland
| | - B Müller
- Biomaterials Science Center, Department of Biomedical Engineering, University of Basel, Allschwil, Switzerland
| | - P Cattin
- Center for medical Image Analysis & Navigation, Department of Biomedical Engineering, University of Basel, Allschwil, Switzerland
| |
Collapse
|
37
|
Müller B, Bohne S, Geißler K, Guntinas-Lichius O. Durchführung und Interpretation der FEES (Fiberoptic Endoscopic Evaluation of
Swallowing). Laryngorhinootologie 2018; 97:160-162. [PMID: 29495039 DOI: 10.1055/s-0043-125008] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/17/2022]
|
38
|
Ribi K, Luo W, Colleoni M, Karlsson P, Chirgwin J, Aebi S, Jerusalem G, Neven P, Di Lauro V, Gomez HL, Ruhstaller T, Abdi E, Di Leo A, Müller B, Maibach R, Gelber RD, Goldhirsch A, Coates AS, Regan MM, Bernhard J. Abstract P5-18-01: Extended continuous vs intermittent adjuvant letrozole in postmenopausal women with lymph node-positive, early breast cancer (IBCSG 37-05/BIG 1-07 SOLE): Impact on patient-reported symptoms and quality of life. Cancer Res 2018. [DOI: 10.1158/1538-7445.sabcs17-p5-18-01] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
Abstract
Background: SOLE efficacy results presented at ASCO 2017 showed that extended intermittent vs continuous letrozole for 5 years did not improve disease-free survival in postmenopausal women who had received 4-6 years of adjuvant endocrine therapy for hormone-receptor positive (HR+), lymph-node positive breast cancer. Previous studies showed that the burden by symptoms related to endocrine therapy can be substantial. Even if symptoms improve during the treatment course, extending treatment implies continuation of symptoms. We compared differences in patient-reported symptoms (PRS) and quality of life (QoL) between extended continuous and intermittent letrozole over the first two years of trial treatment.
Methods: From Nov 2007 to Dec 2010, 956 postmenopausal women who were disease-free following 4-6 years of prior adjuvant endocrine therapy for HR+, node-positive breast cancer were enrolled in the QoL substudy of the randomized phase III trial SOLE at selected centers. Patients receive extended continuous letrozole (2.5 mg daily) for 5 years or intermittent letrozole, taken for the first 9 months of years 1-4, and 12 months in year 5. 955 patients completed the 18-item Breast Cancer Prevention Trial (BCPT) Symptom Scales and further symptom-specific and global QoL indicators at baseline, and at 6, 12, 18 and 24 months after randomization. Differences in change of PRS and QoL from baseline between the two administration schedules were tested at 12 and 24 months for 8 symptom scales, 4 additional symptom and 4 global QoL indicators using mixed models with repeated measures.
Results: Small changes in PRS and QoL scores were observed between baseline and 12 months after randomization, i.e. at the end of the first treatment-free interval in the intermittent arm. These changes showed a consistent pattern of greater worsening for patients receiving continuous compared to patients receiving intermittent letrozole. Patients receiving continuous letrozole reported a significantly greater worsening in vaginal problems (p<.02), musculoskeletal pain (p<.03), sleep disturbance (p<.01), physical wellbeing (p<.01) and mood (p<.03). At 24 months (after 2nd treatment-free interval) patients with intermittent letrozole reported a greater improvement in hot flushes (p<.03) than those with continuous letrozole. Changes in the other outcomes did not significantly differ between arms at 24 months.
Conclusion: Although changes in PRS and QoL were small, there was a consistent pattern favoring the intermittent arm. For several symptoms and global QoL indicators, significantly less worsening was observed with the intermittent administration, mainly during the first year of extended treatment, due to small improvements during the treatment-free interval. Froma QoL perspective, women who suffer from endocrine side-effects in the extended setting may benefit from an intermittent administration.
Citation Format: Ribi K, Luo W, Colleoni M, Karlsson P, Chirgwin J, Aebi S, Jerusalem G, Neven P, Di Lauro V, Gomez HL, Ruhstaller T, Abdi E, Di Leo A, Müller B, Maibach R, Gelber RD, Goldhirsch A, Coates AS, Regan MM, Bernhard J. Extended continuous vs intermittent adjuvant letrozole in postmenopausal women with lymph node-positive, early breast cancer (IBCSG 37-05/BIG 1-07 SOLE): Impact on patient-reported symptoms and quality of life [abstract]. In: Proceedings of the 2017 San Antonio Breast Cancer Symposium; 2017 Dec 5-9; San Antonio, TX. Philadelphia (PA): AACR; Cancer Res 2018;78(4 Suppl):Abstract nr P5-18-01.
Collapse
Affiliation(s)
- K Ribi
- International Breast Cancer Study Group, Breast International Group
| | - W Luo
- International Breast Cancer Study Group, Breast International Group
| | - M Colleoni
- International Breast Cancer Study Group, Breast International Group
| | - P Karlsson
- International Breast Cancer Study Group, Breast International Group
| | - J Chirgwin
- International Breast Cancer Study Group, Breast International Group
| | - S Aebi
- International Breast Cancer Study Group, Breast International Group
| | - G Jerusalem
- International Breast Cancer Study Group, Breast International Group
| | - P Neven
- International Breast Cancer Study Group, Breast International Group
| | - V Di Lauro
- International Breast Cancer Study Group, Breast International Group
| | - HL Gomez
- International Breast Cancer Study Group, Breast International Group
| | - T Ruhstaller
- International Breast Cancer Study Group, Breast International Group
| | - E Abdi
- International Breast Cancer Study Group, Breast International Group
| | - A Di Leo
- International Breast Cancer Study Group, Breast International Group
| | - B Müller
- International Breast Cancer Study Group, Breast International Group
| | - R Maibach
- International Breast Cancer Study Group, Breast International Group
| | - RD Gelber
- International Breast Cancer Study Group, Breast International Group
| | - A Goldhirsch
- International Breast Cancer Study Group, Breast International Group
| | - AS Coates
- International Breast Cancer Study Group, Breast International Group
| | - MM Regan
- International Breast Cancer Study Group, Breast International Group
| | - J Bernhard
- International Breast Cancer Study Group, Breast International Group
| |
Collapse
|
39
|
Müller B, Bohne S, Geißler K, Guntinas-Lichius O. Durchführung und Interpretation der FEES (Fiberoptic Endoscopic Evaluation of
Swallowing). Laryngorhinootologie 2018; 97:86-88. [PMID: 29401545 DOI: 10.1055/s-0043-125007] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
|
40
|
Müller B, Schulz G, Kaiser HJ, Wagenknecht G, Bares R, Büll U, Kupferschläger J. Eine Methode zur kombinierten Scatter- und Schwächungskorrektur ohne Transmissionsmessung für die Myokard-SPECT mit 99mTc- Verbindungen. Nuklearmedizin 2018. [DOI: 10.1055/s-0038-1629735] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/17/2022]
Abstract
Zusammenfassung
Ziel: Für eine Doppelkopf-SPECT-Kamera wird eine Strategie zur Bestimmung der Schwächungsverteilung aus den Zählraten der Rückwärtsstreuung von 99mTc vorgestellt. Ziel war die Gewinnung von segmentierten und normierten Schwächungsbildern mit den Strukturen Lunge und Fett- bzw. Muskelgewebe, so daß nach dem Verfahren von Chang eine Schwächungskorrektur vorgenommen werden kann. Methoden: In den akquirierten Winkelprojektionen wurden sowohl Näherungen für die Schwächung als auch eine Scatterkorrektur nach dem Verfahren von Ogawa et al. berechnet, wobei die Akquisition simultan in drei getrennten 99mTc-Energiefenstern zur Ermittlung von Emissions- und Streustrahlung erfolgt. Anhand von Phantommessungen und Patientenmessungen wurde die Güte der Schwächungsnäherungen und der Schwächungskorrektur untersucht und die beste Wahl für alle auftretenden Parameter zur Schwächungskorrektur ermittelt. Ergebnisse: Das Verfahren stellt eine gute Näherung zur Korrektur der Photonenschwächung und der Streustrahlung dar. Eine Plausibilitäts-kontrolle an Phantom- und beispielhaften Patientenstudien belegte vorläufig auch die klinische Brauchbarkeit. Bei normaler Perfusion wurde die Verteilung homogenisiert, Defekte erschienen klarer. Probleme entstehen bei hohen Non-target-Aktivitäten, z. B. in der Gallenblase, und bei zu geringer Zählrate. Schlußfolgerung: Eine für die 99mTc MIBI-SPECT des Myokards sinnvolle und brauchbare Korrektur von Schwächung und Streuung ist auch ohne zusätzliche Transmissionseinrichtung möglich.
Collapse
|
41
|
Gavdush A, Giuliano B, Müller B, Komandin G, Palumbo M, Baratta G, Sciré C, Yurchenko S, Zaytsev K, Ivlev A, Caselli P. Terahertz time-domain spectroscopy of astrophysical ice analogs: A pilot study. EPJ Web Conf 2018. [DOI: 10.1051/epjconf/201819506004] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
42
|
Behrendt FF, Heinzel A, Müller B, Mottaghy FM, Verburg FA, Krohn T. Pretherapeutic dosimetry before 131I therapy of benign thyroid disease. Nuklearmedizin 2017; 54:131-6. [DOI: 10.3413/nukmed-0692-14-08] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/01/2014] [Accepted: 12/01/2014] [Indexed: 11/20/2022]
Abstract
SummaryAim: To compare uptake measurements and different methods for the pretherapeutic determination of the effective thyroidal 131I half life (Teff) to the results of posttherapeutic dosimetric measurements. Patients, methods: Retrospective study of 1538 patients who received their first RIT in our department for autonomous thyroid nodules (ATN), autonomous multinodular goiter (AMG) or Graves' disease (GD) between November 1999 and January 2011. Pretherapeutic measurements were performed at any combination of 24 h, 48 h and 6 days after 131I administration. Post-therapy dosimetric measurements were performed in 12 h intervals until discharge. Teff was determined through monoexponential curve fitting. Results: Pretherapeutic Teff values based on measurements at 24 h and 48 h, 24 h and 6 d, 48 h and 6 d as well as on day 24 h, 48 h and 6 d yielded implausible (< 2 d or > 8 d) values for Teff, in 60.4%, 25.7%, 29.1 and 21.4% of available calculations, respectively. The plausible results showed significant, clinically relevant and sometimes considerable overestimations of Teff. Using empirically determined fixed disease specific Teff values resulted in a better congruence between the pre- and posttherapeutic dosimetry results. 24 h measurements were marginally more accurate than 48 h ones in AMG and GD whereas 48 h measurements were marginally more accurate in ATN; these differences are however not clinically relevant. 6 d measurements are clearly less accurate than those after 24 h or 48 h. Conclusion: In ATN, AMG and GD, pretherapeutic dosimetry can be performed by a single uptake measurement at 24 h or 48 h using a fixed, disease specific value for Teff. Additional later measurements do not yield a further clinically relevant contribution to accuracy of pretherapeutic dosimetry.
Collapse
|
43
|
Morsbach S, García-Bardon A, Kamuf J, Müller B, Beghersa N, Mohr K, Landfester K. Quantification of fluorescent dyes in organ tissue samples via HPLC analysis. J Chromatogr B Analyt Technol Biomed Life Sci 2017; 1072:34-39. [PMID: 29132023 DOI: 10.1016/j.jchromb.2017.11.012] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/31/2017] [Revised: 11/07/2017] [Accepted: 11/08/2017] [Indexed: 10/18/2022]
Abstract
The determination of regional blood flow via the accumulation of fluorescent microspheres is a concept regularly used in medical research. Typically, the microbeads get extracted from the tissue of interest and are then quantified by measuring the absorption or fluorescence of the incorporated dyes without further separation from the medium. However, in that case the absorption spectra of different dyes can overlap when used simultaneously, leading to an overestimation of the concentration. Additionally, background absorption from the medium can be problematic. Therefore, a high performance liquid chromatography method for the simultaneous detection of four dyes (orange, crimson, yellow-green and red) incorporated in different microbeads in samples from biological media such as organ tissue (brain, heart and kidneys) was developed. Since for biological samples often a large sample size is required for sufficient statistics, the method was optimized to yield very short run times. With this method it was possible to detect very low concentrations of only one microsphere per gram of organ tissue. By applying this sensitive quantification technique, it was demonstrated that the application of microbeads for perfusion measurements might not be reliable due to different organ distributions in each animal.
Collapse
Affiliation(s)
- S Morsbach
- Max Planck Institute for Polymer Research, Ackermannweg 10, Mainz, 55128 Germany.
| | - A García-Bardon
- Department of Anesthesiology, Medical Center of the Johannes Gutenberg University, Langenbeckstraße 1, Mainz, 55131 Germany
| | - J Kamuf
- Department of Anesthesiology, Medical Center of the Johannes Gutenberg University, Langenbeckstraße 1, Mainz, 55131 Germany
| | - B Müller
- Max Planck Institute for Polymer Research, Ackermannweg 10, Mainz, 55128 Germany
| | - N Beghersa
- Department of Anesthesiology, Medical Center of the Johannes Gutenberg University, Langenbeckstraße 1, Mainz, 55131 Germany
| | - K Mohr
- Max Planck Institute for Polymer Research, Ackermannweg 10, Mainz, 55128 Germany
| | - K Landfester
- Max Planck Institute for Polymer Research, Ackermannweg 10, Mainz, 55128 Germany
| |
Collapse
|
44
|
Schulz G, Götz C, Müller-Gerbl M, Zanette I, Zdora MC, Khimchenko A, Deyhle H, Thalmann P, Müller B. Multimodal imaging of the human knee down to the cellular level. ACTA ACUST UNITED AC 2017. [DOI: 10.1088/1742-6596/849/1/012026] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022]
|
45
|
Kind L, Stevanovic S, Wuttig S, Wimberger S, Hofer J, Müller B, Pieles U. Biomimetic Remineralization of Carious Lesions by Self-Assembling Peptide. J Dent Res 2017; 96:790-797. [PMID: 28346861 DOI: 10.1177/0022034517698419] [Citation(s) in RCA: 73] [Impact Index Per Article: 10.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/30/2022] Open
Abstract
Caries is the most common disease in the world. Great efforts have been undertaken for prevention and to identify a regenerative treatment solution for dental caries. Self-assembling β-sheet forming peptides have previously shown to form 3-dimensional fiber networks supporting tissue regeneration. In particular, the self-assembling peptide P11-4 has shown potential in the treatment and prevention of dental caries. It has previously been shown that application of monomeric P11-4 solution to early carious lesions can increase net mineral gain by forming de novo hydroxyapatite crystals. The hypothesis for the mode of action was that monomeric self-assembling peptide P11-4 diffuses into the subsurface lesion body and assembles therein into higher order fibrils, facilitating mineralization of the subsurface volume by mimicking the natural biomineralization of the tooth enamel, and it remains within the lesion body as a scaffold built-in by the newly formed hydroxyapatite. The aim of the present study was to investigate the mechanism of action of the self-assembling peptide P11-4 supporting mineralization of carious enamel. By various analytical methods, it could be shown that the self-assembling peptide P11-4 diffuses into the subsurface lesion, assembles into higher formed aggregates throughout the whole volume of the lesion, and supports nucleation of de novo hydroxyapatite nanocrystals and consequently results in increased mineral density within the subsurface carious lesion. The results showed that the application of self-assembling peptide P11-4 can facilitate the subsurface regeneration of the enamel lesion by supporting de novo mineralization in a similar mode of action as has been shown for the natural formation of dental enamel.
Collapse
Affiliation(s)
- L Kind
- 1 School of Life Sciences, Department of Chemistry and Bioanalytics, University of Applied Sciences and Arts Northwestern Switzerland (FHNW), Muttenz, Switzerland
| | - S Stevanovic
- 1 School of Life Sciences, Department of Chemistry and Bioanalytics, University of Applied Sciences and Arts Northwestern Switzerland (FHNW), Muttenz, Switzerland
| | - S Wuttig
- 1 School of Life Sciences, Department of Chemistry and Bioanalytics, University of Applied Sciences and Arts Northwestern Switzerland (FHNW), Muttenz, Switzerland
| | - S Wimberger
- 1 School of Life Sciences, Department of Chemistry and Bioanalytics, University of Applied Sciences and Arts Northwestern Switzerland (FHNW), Muttenz, Switzerland
| | - J Hofer
- 1 School of Life Sciences, Department of Chemistry and Bioanalytics, University of Applied Sciences and Arts Northwestern Switzerland (FHNW), Muttenz, Switzerland
| | - B Müller
- 2 Department of Biomedical Engineering, University of Basel, Biomaterials Science Center (BMC), Allschwil, Switzerland
| | - U Pieles
- 1 School of Life Sciences, Department of Chemistry and Bioanalytics, University of Applied Sciences and Arts Northwestern Switzerland (FHNW), Muttenz, Switzerland
| |
Collapse
|
46
|
Von Seth M, Hillered L, Otterbeck A, Hanslin K, Larsson A, Sjölin J, Lipcsey M, Cove ME, Chew NS, Vu LH, Lim RZ, Puthucheary Z, Hanslin K, Wilske F, Skorup P, Tano E, Sjölin J, Lipcsey M, Derese I, Thiessen S, Derde S, Dufour T, Pauwels L, Bekhuis Y, Van den Berghe G, Vanhorebeek I, Khan M, Dwivedi D, Zhou J, Prat A, Seidah NG, Liaw PC, Fox-Robichaud AE, Von Seth M, Skorup P, Hillered L, Larsson A, Sjölin J, Lipcsey M, Otterbeck A, Hanslin K, Lipcsey M, Larsson A, Von Seth M, Correa T, Pereira J, Takala J, Jakob S, Skorup P, Maudsdotter L, Tano E, Lipcsey M, Castegren M, Larsson A, Sjölin J, Xue M, Xu JY, Liu L, Huang YZ, Guo FM, Yang Y, Qiu HB, Kuzovlev A, Moroz V, Goloubev A, Myazin A, Chumachenko A, Pisarev V, Takeyama N, Tsuda M, Kanou H, Aoki R, Kajita Y, Hashiba M, Terashima T, Tomino A, Davies R, O’Dea KP, Soni S, Ward JK, O’Callaghan DJ, Takata M, Gordon AC, Wilson J, Zhao Y, Singer M, Spencer J, Shankar-Hari M, Genga KR, Lo C, Cirstea MS, Walley KR, Russell JA, Linder A, Boyd JH, Sedlag A, Riedel C, Georgieff M, Barth E, Debain A, Jonckheer J, Moeyersons W, Van zwam K, Puis L, Staessens K, Honoré PM, Spapen HD, De Waele E, de Garibay APR, Bracht H, Ende-Schneider B, Schreiber C, Kreymann B, Bini A, Votino E, Giuliano G, Steinberg I, Vetrugno L, Trunfio D, Sidoti A, Essig A, Brogi E, Forfori F, Conroy M, Marsh B, O’Flynn J, Henne-Bruns D, Gebhard F, Orend K, Halatsch M, Weiss M, Chase M, Freinkman E, Uber A, Liu X, Cocchi MN, Donnino MW, Peetermans M, Liesenborghs L, Claes J, Vanassche T, Hoylaerts M, Jacquemin M, Vanhoorelbeke K, De Meyer S, Verhamme P, Vögeli A, Ottiger M, Meier M, Steuer C, Bernasconi L, Huber A, Christ-Crain M, Henzen C, Hoess C, Thomann R, Zimmerli W, Müller B, Schütz P, Hoppensteadt D, Walborn A, Rondina M, Tsuruta K, Fareed J, Tachyla S, Ikeda T, Ono S, Ueno T, Suda S, Nagura T, Damiani E, Domizi R, Scorcella C, Tondi S, Pierantozzi S, Ciucani S, Mininno N, Adrario E, Pelaia P, Donati A, Andersen MS, Lu S, Lopez G, Lassen AT, Ghiran I, Shapiro NI, Trahtemberg U, Sviri S, Beil M, Agur Z, Van Heerden P, Jahaj E, Vassiliou A, Mastora Z, Orfanos SE, Kotanidou A, Wirz Y, Sager R, Amin D, Amin A, Haubitz S, Hausfater P, Huber A, Kutz A, Mueller B, Schuetz P, Sager RS, Wirz YW, Amin DA, Amin AA, Hausfater PH, Huber AH, Haubitz S, Kutz A, Mueller B, Schuetz P, Gottin L, Dell’amore C, Stringari G, Cogo G, Ceolagraziadei M, Sommavilla M, Soldani F, Polati E, Meier M, Baumgartner T, Zurauskaité G, Gupta S, Mueller B, Devendra A, Schuetz P, Mandaci D, Eren G, Ozturk F, Emir N, Hergunsel O, Azaiez S, Khedher S, Maaoui A, Salem M, Chernevskaya E, Beloborodova N, Bedova A, Sarshor YU, Pautova A, Gusarov V, Öveges N, László I, Forgács M, Kiss T, Hankovszky P, Palágyi P, Bebes A, Gubán B, Földesi I, Araczki Á, Telkes M, Ondrik Z, Helyes Z, Kemény Á, Molnár Z, Spanuth E, Ebelt H, Ivandic B, Thomae R, Werdan K, El-Shafie M, Taema K, El-Hallag M, Kandeel A, Tayeh O, Taema K, Eldesouky M, Omara A, Winkler MS, Holzmann M, Nierhaus A, Mudersbach E, Schwedhelm E, Daum G, Kluge S, Zoellner C, Greiwe G, Sawari H, Schwedhelm E, Nierhaus A, Kluge S, Kubitz J, Jung R, Daum G, Reichenspurner H, Zoellner C, Winkler MS, Groznik M, Ihan A, Andersen LW, Chase M, Holmberg MJ, Wulff A, Cocchi MN, Donnino MW, Balci C, Haliloglu M, Bilgili B, Bilgin H, Kasapoglu U, Sayan I, Süzer M, Mulazımoglu L, Cinel I, Patel V, Shah S, Parulekar P, Minton C, Patel J, Ejimofo C, Choi H, Costa R, Caruso P, Nassar P, Fu J, Jin J, Xu Y, Kong J, Wu D, Yaguchi A, Klonis A, Ganguly S, Kollef M, Burnham C, Fuller B, Mavrommati A, Chatzilia D, Salla E, Papadaki E, Kamariotis S, Christodoulatos S, Stylianakis A, Alamanos G, Simoes M, Trigo E, Silva N, Martins P, Pimentel J, Baily D, Curran LA, Ahmadnia E, Patel BV, Adukauskiene D, Cyziute J, Adukauskaite A, Pentiokiniene D, Righetti F, Colombaroli E, Castellano G, Wilske F, Skorup P, Lipcsey M, Hanslin K, Larsson A, Sjölin J, Man M, Shum HP, Chan YH, Chan KC, Yan WW, Lee RA, Lau SK, Dilokpattanamongkol P, Thirapakpoomanunt P, Anakkamaetee R, Montakantikul P, Tangsujaritvijit V, Sinha S, Pati J, Sahu S, Adukauskiene D, Valanciene D, Dambrauskiene A, Adukauskiene D, Valanciene D, Dambrauskiene A, Hernandez K, Lopez T, Saca D, Bello M, Mahmood W, Hamed K, Al Badi N, AlThawadi S, Al Hosaini S, Salahuddin N, Cilloniz CC, Ceccato AC, Bassi GLL, Ferrer MF, Gabarrus AG, Ranzani OR, Jose ASS, Vidal CGG, de la Bella Casa JPP, Blasi FB, Torres AT, Adukauskiene D, Ciginskiene A, Dambrauskiene A, Simoliuniene R, Giuliano G, Triunfio D, Sozio E, Taddei E, Brogi E, Sbrana F, Ripoli A, Bertolino G, Tascini C, Forfori F, Fleischmann C, Goldfarb D, Schlattmann P, Schlapbach L, Kissoon N, Baykara N, Akalin H, Arslantas MK, Gavrilovic SG, Vukoja MV, Hache MH, Kashyap RK, Dong YD, Gajic OG, Ranzani O, Shankar-Hari M, Harrison D, Rabello L, Rowan K, Salluh J, Soares M, Markota AM, Fluher JF, Kogler DK, Borovšak ZB, Sinkovic AS, László I, Öveges N, Forgács M, Kiss T, Hankovszky P, Palágyi P, Bebes A, Gubán B, Földesi I, Araczki Á, Telkes M, Ondrik Z, Helyes Z, Kemény Á, Molnár Z, Fareed J, Siddiqui Z, Aggarwal P, Iqbal O, Hoppensteadt D, Lewis M, Wasmund R, Abro S, Raghuvir S, Tsuruta K, Barie PS, Fineberg D, Radford A, Tsuruta K, Casazza A, Vilardo A, Bellazzi E, Boschi R, Ciprandi D, Gigliuto C, Preda R, Vanzino R, Vetere M, Carnevale L, Kyriazopoulou E, Pistiki A, Routsi C, Tsangaris I, Giamarellos-Bourboulis E, Kyriazopoulou E, Tsangaris I, Routsi C, Pnevmatikos I, Vlachogiannis G, Antoniadou E, Mandragos K, Armaganidis A, Giamarellos-Bourboulis E, Allan P, Oehmen R, Luo J, Ellis C, Latham P, Newman J, Pritchett C, Pandya D, Cripps A, Harris S, Jadav M, Langford R, Ko B, Park H, Beumer CM, Koch R, Beuningen DV, Oudelashof AM, Vd Veerdonk FL, Kolwijck E, VanderHoeven JG, Bergmans DC, Hoedemaekers C, Brandt JB, Golej J, Burda G, Mostafa G, Schneider A, Vargha R, Hermon M, Levin P, Broyer C, Assous M, Wiener-Well Y, Dahan M, Benenson S, Ben-Chetrit E, Faux A, Sherazi R, Sethi A, Saha S, Kiselevskiy M, Gromova E, Loginov S, Tchikileva I, Dolzhikova Y, Krotenko N, Vlasenko R, Anisimova N, Spadaro S, Fogagnolo A, Remelli F, Alvisi V, Romanello A, Marangoni E, Volta C, Degrassi A, Mearelli F, Casarsa C, Fiotti N, Biolo G, Cariqueo M, Luengo C, Galvez R, Romero C, Cornejo R, Llanos O, Estuardo N, Alarcon P, Magazi B, Khan S, Pasipanodya J, Eriksson M, Strandberg G, Lipsey M, Larsson A, Rajput Z, Hiscock F, Karadag T, Uwagwu J, Jain S, Molokhia A, Barrasa H, Soraluce A, Uson E, Rodriguez A, Isla A, Martin A, Fernández B, Fonseca F, Sánchez-Izquierdo JA, Maynar FJ, Kaffarnik M, Alraish R, Frey O, Roehr A, Stockmann M, Wicha S, Shortridge D, Castanheira M, Sader HS, Streit JM, Flamm RK, Falsetta K, Lam T, Reidt S, Jancik J, Kinoshita T, Yoshimura J, Yamakawa K, Fujimi S, Armaganidis A, Torres A, Zakynthinos S, Mandragos C, Giamarellos-Bourboulis E, Ramirez P, De la Torre-Prados M, Rodriguez A, Dale G, Wach A, Beni L, Hooftman L, Zwingelstein C, François B, Colin G, Dequin PF, Laterre PF, Perez A, Welte R, Lorenz I, Eller P, Joannidis M, Bellmann R, Lim S, Chana S, Patel S, Higuera J, Cabestrero D, Rey L, Narváez G, Blandino A, Aroca M, Saéz S, De Pablo R, Thiessen S, Vanhorebeek I, Derde S, Derese I, Dufour T, Albert CN, Langouche L, Goossens C, Peersman N, Vermeersch P, Vander Perre S, Holst J, Wouters P, Van den Berghe G, Liu X, Uber AU, Holmberg M, Konanki V, McNaughton M, Zhang J, Donnino MW, Demirkiran O, Byelyalov A, Luengo C, Guerrero J, Cariqueo M, Scorcella C, Domizi R, Damiani E, Tondi S, Pierantozzi S, Rossini N, Falanga U, Monaldi V, Adrario E, Pelaia P, Donati A, Cole O, Scawn N, Balciunas M, Blascovics I, Vuylsteke A, Salaunkey K, Omar A, Salama A, Allam M, Alkhulaifi A, Verstraete S, Vanhorebeek I, Van Puffelen E, Derese I, Ingels C, Verbruggen S, Wouters P, Joosten K, Hanot J, Guerra G, Vlasselaers D, Lin J, Van den Berghe G, Haines R, Zolfaghari P, Hewson R, Offiah C, Prowle J, Park H, Ko B, Buter H, Veenstra JA, Koopmans M, Boerma EC, Veenstra JA, Buter H, Koopmans M, Boerma EC, Taha A, Shafie A, Hallaj S, Gharaibeh D, Hon H, Bizrane M, El Khattate AA, Madani N, Abouqal R, Belayachi J, Kongpolprom N, Sanguanwong N, Sanaie S, Mahmoodpoor A, Hamishehkar H, Biderman P, Van Heerden P, Avitzur Y, Solomon S, Iakobishvili Z, Carmi U, Gorfil D, Singer P, Paisley C, Patrick-Heselton J, Mogk M, Humphreys J, Welters I, Pierantozzi S, Scorcella C, Domizi R, Damiani E, Tondi S, Casarotta E, Bolognini S, Adrario E, Pelaia P, Donati A, Holmberg MJ, Moskowitz A, Patel P, Grossestreuer A, Uber A, Andersen LW, Donnino MW, Malinverni S, Goedeme D, Mols P, Langlois PL, Szwec C, D’Aragon F, Heyland DK, Manzanares W, Manzanares W, Szwec C, Langlois P, Aramendi I, Heyland D, Stankovic N, Nadler J, Uber A, Holmberg M, Sanchez L, Wolfe R, Chase M, Donnino M, Cocchi M, Atalan HK, Gucyetmez B, Kavlak ME, Aslan S, Kargi A, Yazici S, Donmez R, Polat KY, Piechota M, Piechota A, Misztal M, Bernas S, Pietraszek-Grzywaczewska I, Saleh M, Hamdy A, Hamdy A, Elhallag M, Atar F, Kundakci A, Gedik E, Sahinturk H, Zeyneloglu P, Pirat A, Popescu M, Tomescu D, Van Gassel R, Baggerman M, Schaap F, Bol M, Nicolaes G, Beurskens D, Damink SO, Van de Poll M, Horibe M, Sasaki M, Sanui M, Iwasaki E, Sawano H, Goto T, Ikeura T, Hamada T, Oda T, Mayumi T, Kanai T, Kjøsen G, Horneland R, Rydenfelt K, Aandahl E, Tønnessen T, Haugaa H, Lockett P, Evans L, Somerset L, Ker-Reid F, Laver S, Courtney E, Dalton S, Georgiou A, Robinson K, Lam T, Haas B, Reidt S, Bartlett K, Jancik J, Bigwood M, Hanley R, Morgan P, Marouli D, Chatzimichali A, Kolyvaki S, Panteli A, Diamantaki E, Pediaditis E, Sirogianni P, Ginos P, Kondili E, Georgopoulos D, Askitopoulou H, Zampieri FG, Liborio AB, Besen BA, Cavalcanti AB, Dominedò C, Dell’Anna AM, Monayer A, Grieco DL, Barelli R, Cutuli SL, Maddalena AI, Picconi E, Sonnino C, Sandroni C, Antonelli M, Gucyetmez B, Atalan HK, Tuzuner F, Cakar N, Jacob M, Sahu S, Singh YP, Mehta Y, Yang KY, Kuo S, Rai V, Cheng T, Ertmer C, Czempik P, Hutchings S, Watts S, Wilson C, Burton C, Kirkman E, Drennan D, O’Prey A, MacKay A, Forrest R, Oglinda A, Ciobanu G, Casian M, Oglinda C, Lun CT, Yuen HJ, Ng G, Leung A, So SO, Chan HS, Lai KY, Sanguanwit P, Charoensuk W, Phakdeekitcharoen B, Batres-Baires G, Kammerzell I, Lahmer T, Mayr U, Schmid R, Huber W, Spanuth E, Bomberg H, Klingele M, Thomae R, Groesdonk H, Bernas S, Piechota M, Mirkiewicz K, Pérez AG, Silva J, Ramos A, Acharta F, Perezlindo M, Lovesio L, Antonelli PG, Dogliotti A, Lovesio C, Baron J, Schiefer J, Baron DM, Faybik P, Shum HP, Yan WW, Chan TM, Marouli D, Chatzimichali A, Kolyvaki S, Panteli A, Diamantaki E, Pediaditis E, Sirogianni P, Ginos P, Kondili E, Georgopoulos D, Askitopoulou H, Vicka V, Gineityte D, Ringaitiene D, Sipylaite J, Pekarskiene J, Beurskens DM, Van Smaalen TC, Hoogland P, Winkens B, Christiaans MH, Reutelingsperger CP, Van Heurn E, Nicolaes GA, Schmitt FS, Salgado ES, Friebe JF, Fleming TF, Zemva JZ, Schmoch TS, Uhle FU, Kihm LK, Morath CM, Nusshag CN, Zeier MZ, Bruckner TB, Mehrabi AM, Nawroth PN, Weigand MW, Hofer SH, Brenner TB, Fotopoulou G, Poularas I, Kokkoris S, Brountzos E, Zakynthinos S, Routsi C, Saleh M, Elghonemi M, Nilsson KF, Sandin J, Gustafsson L, Frithiof R, Skorniakov I, Varaksin A, Vikulova D, Shaikh O, Whiteley C, Ostermann M, Di Lascio G, Anicetti L, Bonizzoli M, Fulceri G, Migliaccio ML, Sentina P, Cozzolino M, Peris A, Khadzhynov D, Halleck F, Staeck O, Lehner L, Budde K, Slowinski T, Slowinski T, Kindgen-Milles D, Khadzhynov D, Huysmans N, Laenen MV, Helmschrodt A, Boer W. 37th International Symposium on Intensive Care and Emergency Medicine (part 3 of 3). Crit Care 2017. [PMCID: PMC5374592 DOI: 10.1186/s13054-017-1629-x] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/21/2022] Open
|
47
|
|
48
|
Winzeler B, Lengsfeld S, Nigro N, Suter-Widmer I, Schütz P, Arici B, Bally M, Blum C, Bock A, Huber A, Müller B, Christ-Crain M. Predictors of nonresponse to fluid restriction in hyponatraemia due to the syndrome of inappropriate antidiuresis. J Intern Med 2016; 280:609-617. [PMID: 27481546 DOI: 10.1111/joim.12532] [Citation(s) in RCA: 23] [Impact Index Per Article: 2.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 12/13/2022]
Abstract
BACKGROUND Fluid restriction (FR), the first-line treatment for hyponatraemia due to the syndrome of inappropriate antidiuresis (SIAD), often does not lead to successful correction of hyponatraemia. Therefore, predictive markers of treatment response are desirable. We evaluated routinely measured serum (s) and urine (u) parameters, s-copeptin and s-mid-regional pro-atrial natriuretic peptide (s-MR-proANP), as possible predictors of FR response. METHODS In this prospective observational study, we included patients with profound hyponatraemia (s-sodium <125 mmol L-1 ) due to SIAD. Patients were classified as FR responders (increase in s-sodium concentration of >3 mmol L-1 within 24 h) or nonresponders (increase of ≤3 mmol L-1 within 24 h). Initial laboratory parameters were compared between groups with logistic regression analysis. RESULTS Of 106 SIAD patients analysed, 82 underwent treatment with FR; 48 (59%) patients showed a successful response to FR and 34 (41%) were considered nonresponders. High levels of u-sodium and u-osmolality were significantly associated with nonresponse to FR [odds ratio (OR) 15.0, 95% confidence interval (CI) 2.4-95.8, P = 0.004 and OR 34.8, 95% CI 1.2-1038.8, P = 0.041, respectively). The association of u-sodium and nonresponse remained significant also after adjustment for diuretic use. Lower levels of s-MR-proANP were associated with nonresponse (OR 0.03, 95% CI 0.003-0.3, P = 0.004), whereas s-copeptin was not significantly associated with response to FR. CONCLUSION Easily measured laboratory parameters, especially u-sodium, correlate with therapeutic response and identify patients most likely to fail to respond to FR. Measurement of these parameters may facilitate early treatment choice in patients with SIAD.
Collapse
Affiliation(s)
- B Winzeler
- Department of Internal Medicine, Division of Endocrinology, Diabetes and Metabolism, University Hospital Basel, Basel, Switzerland
| | - S Lengsfeld
- Department of Internal Medicine, Division of Endocrinology, Diabetes and Metabolism, University Hospital Basel, Basel, Switzerland
| | - N Nigro
- Department of Internal Medicine, Division of Endocrinology, Diabetes and Metabolism, University Hospital Basel, Basel, Switzerland
| | - I Suter-Widmer
- Department of Internal Medicine, Division of Endocrinology, Diabetes and Metabolism, University Hospital Basel, Basel, Switzerland
| | - P Schütz
- Division of Endocrinology, Diabetology and Metabolism, University Medical Clinic Aarau, Aarau, Switzerland
| | - B Arici
- Department of Internal Medicine, Division of Endocrinology, Diabetes and Metabolism, University Hospital Basel, Basel, Switzerland
| | - M Bally
- Division of Endocrinology, Diabetology and Metabolism, University Medical Clinic Aarau, Aarau, Switzerland
| | - C Blum
- Division of Endocrinology, Diabetology and Metabolism, University Medical Clinic Aarau, Aarau, Switzerland
| | - A Bock
- Department of Internal Medicine, Division of Nephrology, Dialysis and Transplantation, University Medical Clinic Aarau, Aarau, Switzerland
| | - A Huber
- Institute of Laboratory Medicine, University Medical Clinic Aarau, Aarau, Switzerland
| | - B Müller
- Division of Endocrinology, Diabetology and Metabolism, University Medical Clinic Aarau, Aarau, Switzerland
| | - M Christ-Crain
- Department of Internal Medicine, Division of Endocrinology, Diabetes and Metabolism, University Hospital Basel, Basel, Switzerland
| |
Collapse
|
49
|
Müller B, Geißler K, Guntinas-Lichius O. [The Sensory Organization Test on the Equitest® posturography system]. Laryngorhinootologie 2016; 95:602-3. [PMID: 27636686 DOI: 10.1055/s-0042-114542] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/21/2022]
|
50
|
Joussen AM, Strauß O, Winterhalter S, Klamann M, Dietrich-Ntoukas T, Müller B. [Ocular Hypotension: How the Retina Surgeon Sees the Causes and Therapeutic Options]. Klin Monbl Augenheilkd 2016; 233:1024-32. [PMID: 27617647 DOI: 10.1055/s-0042-109708] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/21/2022]
Abstract
Ocular hypotension is a result of a lack of production or a loss of intraocular fluid. Intraocular inflammation, drugs, or proliferative vitreoretinopathy (PVR) with overgrowth of the ciliary body can result in reduced secretion of intraocular fluid. Loss of intraocular fluid can result from external loss, such as in fistulating surgery or trauma, or internally, e.g. from cyclodialysis clefts or retinal detachment. In this review, we discuss the causal therapy of ocular hypotension: fixation of the ciliary body, removal of ciliary body membranes, surgery for PVR, choice of tamponade, possibilities and limitations of an iris diaphragm, and pharmacological options.
Collapse
Affiliation(s)
- A M Joussen
- Klinik für Augenheilkunde, Charité - Universitätsmedizin Berlin
| | - O Strauß
- Klinik für Augenheilkunde, Charité - Universitätsmedizin Berlin
| | - S Winterhalter
- Klinik für Augenheilkunde, Charité - Universitätsmedizin Berlin
| | - M Klamann
- Klinik für Augenheilkunde, Charité - Universitätsmedizin Berlin
| | | | - B Müller
- Klinik für Augenheilkunde, Charité - Universitätsmedizin Berlin
| |
Collapse
|